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ABSTRACT OF THE DISSERTATION 
DEVELOPMENT OF MICRO IMMUNOSENSORS TO STUDY GENOMIC AND 
PROTEOMIC BIOMARKERS RELATED TO CANCER AND ALZHEIMER’S 
DISEASE 
by 
Shradha Prabhulkar 
Florida International University, 2011 
Miami, Florida 
Professor Chenzhong Li, Major Professor 
A report from the National Institutes of Health defines a disease biomarker as a 
"characteristic that is objectively measured and evaluated as an indicator of normal 
biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic 
intervention." Early diagnosis is a crucial factor for incurable disease such as cancer and 
Alzheimer’s disease (AD). During the last decade researchers have discovered that 
biochemical changes caused by a disease can be detected considerably earlier as 
compared to physical manifestations/symptoms. In this dissertation electrochemical 
detection was utilized as the detection strategy as it offers high sensitivity/specificity, 
ease of operation, and capability of miniaturization and multiplexed detection. 
Electrochemical detection of biological analytes is an established field, and has matured 
at a rapid pace during the last 50 years and adapted itself to advances in 
micro/nanofabrication procedures. Carbon fiber microelectrodes were utilized as the 
platform sensor due to their high signal to noise ratio, ease and low-cost of fabrication, 
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biocompatibility, and active carbon surface which allows conjugation with bio-
recognition moieties. 
This dissertation specifically focuses on the detection of 3 extensively validated 
biomarkers for cancer and AD. Firstly, vascular endothelial growth factor (VEGF) a 
cancer biomarker was detected using a one-step, reagentless immunosensing strategy. 
The immunosensing strategy allowed a rapid and sensitive means of VEGF detection 
with a detection limit of about 38 pg/mL with a linear dynamic range of 0–100 pg/mL. 
Direct detection of AD-related biomarker amyloid beta (Aβ) was achieved by exploiting 
its inherent electroactivity. The quantification of the ratio of Aβ1-40/42 (or Aβ ratio) has 
been established as a reliable test to diagnose AD through human clinical trials. Triple 
barrel carbon fiber microelectrodes were used to simultaneously detect Aβ1-40 and Aβ1-
42 in cerebrospinal fluid from rats within a detection range of 100nM to 1.2μM and 
400nM to 1μM respectively. 
In addition, the release of DNA damage/repair biomarker 8-hydroxydeoxyguanine 
(8-OHdG) under the influence of reactive oxidative stress from single lung endothelial 
cell was monitored using an activated carbon fiber microelectrode. The sensor was used 
to test the influence of nicotine, which is one of the most biologically active chemicals 
present in cigarette smoke and smokeless tobacco.  
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Chapter 1 
Introduction 
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1.1. Motivation 
 
The motivation of the dissertation was to develop sensors to detect disease biomarkers in 
patient body fluids and at the surface of single cells. Monitoring disease biomarkers allow 
early disease diagnosis as biomolecular changes occur earlier as compared to any 
physical symptoms. Disease progression and response to therapy can also be monitored 
by measuring biomarkers in patient fluid samples. Electrochemical sensors were used as 
the platform technology as they provide several key advantages such as miniaturization, 
high sensitivity, and fast response time. The goal of the dissertation was to develop 
direct, one-step immunosensors to measure all types of disease biomarkers. Biomarkers 
can be broadly classified as electroactive and the non-electroactive biomarkers, as the 
platform technology used was electrochemistry.  
 
1.2. Specific Aims 
 
Specific Aim 1: Development of amperometric immunosensor for detection of non-
electroactive biomarkers in patient fluid samples.  
More than 90% of the bio-molecules present in the human body are non-electroactive. 
Any of these bio-molecules may act biomarkers towards a specific disease. Thus the first 
aim of the dissertation research was to develop a highly sensitive, one-step detection 
strategy to measure non-electroactive bio-molecules in patient fluid samples. Vascular 
endothelial growth factor was used a model non-electroactive analyte as it is highly 
overexpressed by tumor tissue. 
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Specific Aim 2: Development of amperometric immunosensor for multiplex detection of 
electroactive biomarkers in patient fluid samples.  
Many interesting biomolecules such as neurotransmitters, prostrate specific antigen, 
hemoglobin etc. are electroactive due to the presence of metallic co-factors or active 
amino acids such as tyrosine, trytophan, cysteine, and glycine. The second aim deals with 
the development of a direct sensing strategy to detect these electroactive biomolecules. 
Multiplex detection allows simultaneous detection two or three different biomarkers 
which enables earlier disease diagnosis with better accuracy. Electroactive protein 
biomarkers – Amyloid beta 40 and 42 related to Alzheimer’s disease were used as model 
analytes.  
 
Specific Aim 3: Development of a sensing strategy to detect biomarkers at the surface of 
single cells. 
Monitoring biomarker release at the surface of a single cell enables the study of the 
underlying cause of disease and factors influencing disease progression. Single cells 
maintain all their physiological activities and can be monitored without the interference 
of other biological components and mechanisms present in the body. In order to study 
biomarkers at the surface of single cells, an electroactive DNA damage biomarker known 
as 8-hydroxydeoxyguanine was used as the model analyte.    
 
1.3. Biomarkers  
Biomarkers comprise of cellular molecules such as proteins or nucleic acids that can be 
detected in cells, blood, urine, or other body fluids and are over-expressed due to the 
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onset of disease. To date a wide range of biomarkers have been identified for different 
types of diseases and have made their way into translational medicine. These include 
DNA modifications, RNA, proteins (enzymes and glycoproteins), hormones and related 
molecules, molecules of the immune system, oncogenes and other modified molecules. 
The DNA-based markers include single nucleotide polymorphisms (Aly et al., 2011), 
chromosomal aberrations (Rossner et al., 2011), changes in DNA copy number (Nakao et 
al., 2011), microsatellite instability (Kloor et al., 2005), and differential promoter-region 
methylation (Das and Singal, 2004). The RNA-based biomarkers include overexpressed 
or underexpressed transcripts, and regulatory RNAs (Sunde, 2010). The protein markers 
include cell-surface receptors such as CD20 (Dorner et al., 2010), tumour antigens such 
as prostate-specific antigen (Tosoian and Loeb, 2010), phosphorylation states (Moran et 
al., 2006), carbohydrate determinants, and peptides released by tumors into serum, urine, 
sputum, nipple aspirates or other body fluids. New developments in the fields of 
proteomics and genomics research are resulting in the rapid identification of novel 
biomarkers. High throughput detection strategies and toxicology studies are enabling the 
identification of antigens towards disease diagnosis. Protein micro-arrays, serological 
analysis of recombinant cDNA expression libraries (SEREX), and serological proteome 
analysis (SERPA) technologies have been successfully used towards the detection of 
biomarkers related to cancer and AD. FDA officials are collaborating with researchers 
from drug companies, government agencies and academic institutes to develop a list of 
validated biomarkers that signal disease progression and drug safety and efficacy. 
According to FDA’s draft guidance, there are four different types of biomarkers: 
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• Prognostic biomarkers are used to determine the disease progression in a patient. 
• Predictive biomarkers are a baseline characteristic that indicate the likelihood a specific 
patient will respond to a given treatment. 
• Pharmocodynamic biomarkers test the biological response that occurred in a patient 
after receiving a particular drug, such as a change in blood pressure or cholesterol. 
Drug companies usually test these biomarkers in phase II clinical trials and submit the 
results to the FDA; however, actual drug approval is generally based on harder clinical 
endpoints. 
• Surrogate endpoints are biomarkers that are intended to be used as a substitute for a 
clinical efficacy endpoint. 
Numerous biomarkers are still going through evaluation to improve their specificity and 
sensitivity in the context of their clinical use. The field of biomarker discovery is based 
on a close collaboration between clinicians, analytical scientists and 
chemometritians/statisticians. Defining the final purpose of a biomarker or biomarker 
pattern at the onset of a study enables appropriate selection case and control samples, 
design of experiments, sample collection, storage and separation protocols, choice and 
validation of the quantitative profiting platform followed by data processing, statistical 
analysis and validation workflows. Biomarker candidates that result after statistical 
validation need be submitted for further validation. Preferably another clinical center 
should be assigned to assess the specificity and sensitivity of a given biomarker-based 
assay in a larger set of independent samples (Horvatovich and Bischoff, 2010). In order 
to make the process of disease biomarker discovery transparent, accessible, and easily 
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understood in the context of its conclusions, stringent guidelines have been established 
(McShane et al., 2005). 
1.4. Biosensor 
 
1.4.1. Historical Survey 
Research efforts have focused for the last several decades on improving the “quality of 
human life”. Control of disease, quality of food/water and environmental safety are 
closely linked to these efforts. The development of biosensors which incorporates the 
well established chemical sensing techniques with a bio-recognition element has drawn 
the interest of the food-industry, bio-industry, medical, and environmental control 
industries. The capabilities of biosensors to combine continuous, selective, high 
sensitivity, and fast monitoring make them indispensable (Newman and Setford, 2006).  
Clark et al. and others first introduced biosensors in the 1950’s combining physically 
entrapped enzymes to an electrochemical transducer (Leland C. Clark Jr, 1962; Sharmat 
and Rogers, 1994). During the last several decades the field of biosensors has grown 
exponentially with research teams involving researchers with different backgrounds such 
as physicists, chemists, medical researchers and engineers.  In a recently published 
comprehensive report by Global Industry Analysts, the global market for biosensors is 
predicted to reach US $12 billion by the year 2015, with point-of-care testing devices 
such as the glucose sensor representing the largest segment (Global Industry Analysts, 
2011). Growth in population and the increase in the number of people suffering from 
lifestyle related issues such as obesity and diabetes is driving this market growth due to 
the need for periodic medical testing. R&D activities related to healthcare are also rising 
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with biosensors required for applications such as drug discovery, drug analysis, and for 
in-vivo testing of pharmacodynamic effects of new drug candidates.  
 
1.4.2. Definition and classification of biosensor 
A biosensor can be broadly defined as an analytical device that converts a biological 
response, based on the composition, structure or function of a biological system, into an 
electrical signal. Biosensors are often used to determine the concentration of substances 
or to monitor a biological system. (Leland C. Clark Jr, 1962). 
Biosensor broadly consists of 3 parts: 
• The biological recognition element, which can be, but are not limited to tissue, 
microorganisms, organelles, cell receptors, enzymes, antibodies, nucleic acids, 
etc. 
• The transducer or the detector element (optical, piezoelectric, electrochemical, 
thermal, magnetic etc.) that transforms the signal resulting from the interaction of 
the analyte of interest with the bio-recognition element into a signal that can be 
measured and quantified. 
• The detector, which consists of associated electronics or signal processors that are 
primarily responsible for the display of the results in a user-friendly way. The 
detector often accounts for the most expensive and bulky part of the biosensor 
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device. 
 
Figure 1.1. A schematic illustration of the functional components of a biosensor.  
A successful biosensor must possess most of the following beneficial features:  
1. The bio-recognition element must be highly specific for the purpose of the 
analysis, and be stable under normal storage conditions.  
2. The reaction between the bio-recognition element and analyte of interest should 
be as independent of physical parameters such as stirring, pH and temperature. 
This would allow the analysis of samples to be conducted with minimal pre-
treatment.  
3. The response of the biosensor should be accurate, precise, reproducible and linear 
over a relevant analytical range, without dilution or concentration. The signal to 
noise ratio of the biosensor should be high.   
4. If the biosensor is to be used for in-vivo monitoring in clinical situations, the 
probe must be tiny and biocompatible, having no toxic or antigenic effects. If the 
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sensor is reusable then it should be able to withstand standard sterilization 
procedures.  
5. The complete biosensor should be cheap, small, portable and capable of being 
used by semi-skilled operators.  
6. There should be a market for the biosensor. There is no benefit to developing a 
biosensor if other factors (e.g. government subsidies, the continued employment 
of skilled analysts, or poor customer perception) encourage the use of traditional 
methods and discourage the decentralization of laboratory testing. 
 
1.5. Electrochemical Biosensors 
Electrochemical sensors have been favored over optical sensors mainly due to numerous 
factors such as 1) they are low cost, 2) they can be miniaturized for in-vivo applications 
or can be made portable for in-field applications 3) they can be mass-produced using 
standard micro/nano fabrication cleanroom facilities. Based on the electrochemical 
property to be measured the electrochemical sensors can be classified as potentiometric, 
amperometric or conductimetric.  
Potentiometric biosensors make use of ion-selective electrodes such as in order to 
transduce the biological reaction into an electrical signal. In the simplest terms this 
consists of an immobilized enzyme membrane surrounding the probe from a pH-meter, 
where the catalyzed reaction generates or absorbs hydrogen ions. The reaction occurring 
next to the thin sensing glass membrane causes a change in pH, which may be read 
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directly from the pH-meter's display. Typical of the use of such electrodes is that the 
electrical potential is determined at very high impedance allowing effectively zero 
current flow and causing no interference with the reaction. The basis of this type of 
biosensor is the Nerst equation that relates the electrode potential (E) to the concentration 
of the electroactive species present in buffer solution.  
For the reaction: aA + ne- ↔ bB, the Nerst equation is described as follows: 
 
E = E 0 +
RT
nF
{
CA
a
CB
b }   (1.1)      
Where E0 is the standard redox potential, R is the gas constant, T is the absolute 
temperature, F is the Faraday constant, n is the number of electrons exchanged in the 
reaction, and CA and CB are the concentrations of the oxidized and reduced species. A 
typical application of potentiometric sensors was developed to measure glucose 
(Kuffmann and Guibault 1991). Glucose has minimal effect on pH, however the 
enzymatically formed product of glucose and glucose oxidase immobilized on the sensor 
outer surface of a pH electrodes causes acidification and thus results in a signal change. 
Semiconductor based physio-chemical transducers are commonly used in ISFETs (ion-
selective field effect transistors) and LAPS (light addressable potentiometric sensor) 
(Yuqing et al. 2003 and 2005; Yoshinobu et al. 2005). The working principle of the 
ISFET sensor is related to a local potential generated at the surface of the sensor by ions 
from solution. Potentiometric sensors using semiconductor sensors have been 
successfully developed for the detection of herbicide atrazine (D’ Agostino et al., 2006), 
neurotransmitter serotonin (Kitade et al., 2004), creatinine (Karakus et al., 2006), 
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glycoalkaloids (Korpan et al., 2006), and organophosphate pesticides (Timur and 
Telefoncu 2004). The LAPS biosensor has been used for the detection of as low as 10 
cells/ml of Escherichia coli and has been commercialized for an automated 8-channel 
device for detection of biological agents (Ercole et al., 2002). 
Amperometric sensors are based on the measurement of the current resulting from the 
electrochemical oxidation or reduction of an electroactive species in solution or at the 
surface of the electrode. Amperometric sensors are more sensitive and suitable for mass 
production as compared to potentiometric sensors. The working electrode in an 
amperometric sensor usually consists of a noble metal such as Pt, Au or a carbonaceous 
material such as glassy carbon, carbon paste, screen printed carbon-ink etc. 
Amperometric sensors can work in a two- or three-electrode configuration based on the 
application. The first case consists of the working (contains bio-recognition element) and 
reference electrodes. The main shortcoming of the two-electrode configuration is the 
short linear range obtained due to limited control of the potential on the working 
electrode surface with higher currents. A third auxillary electrode is employed to solve 
this problem. Therefore, in the three-electrode configuration voltage is applied between 
the reference and the working electrodes, and current flows between the working and the 
auxillary electrodes. Using amperometric sensors in the 3-electrode configuration 
currents as low as 10−9 to 10−6 A can be easily measured. The resulting current is directly 
correlated to the bulk concentration of the electroactive species or its production or 
consumption rate within the adjacent biocatalytic layer. As biocatalytic reaction rates are 
often chosen to be first order dependent on the bulk analyte concentration, such steady-
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state currents are usually proportional to the bulk analyte concentration. Amperometric 
sensors have often been used on a large scale for detection of analytes such as glucose, 
lactate (Ohnuki et al., 2007) and salicylic acid (Marzouk et al., 2007). Biosensors 
utilizing enzymes such as acetylcholinesterase and butyrylcholinesterase have been 
employed for the rapid detection of organophosphates and carbamates.  Detection of 
cancer marker genes such as BRAC1 and BRAC2 from breast tissue has been 
accomplished using the catalytic oxidation of guanine nucleobase (Tansil et al., 2005).   
Amperometric and potentiometric transducers have been used commonly for biosensor 
development, but much attention in recent years has been devoted towards impedance 
based transducers as they can accomplish label-free analysis. Conductimetric biosensors 
follow the changes in conductance or impedance of a solution as a result of the 
biorecognition component using a noble element working electrode. Thus the expression 
of impedance or its inverse conductance is as follows, where Z is impedance, R is 
component resistance, C is component capacitance: 
 
Z 2 = R2 +
1
(2 fC)2
 (1.2) 
Conductimetric biosensors include two electrodes with applied alternating voltage, 
amplitudes from a few to 100 mV can be used. Biosensors based on the conductimetric 
principle present a number of advantages: a) thin-film electrodes are suitable for 
miniaturization and large scale production using inexpensive technology, b) they do not 
require any reference electrode, c) transducers are not light sensitive, d) the driving 
voltage can be sufficiently low to decrease significantly the power consumption, e) large 
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spectrum of compounds of different nature can be determined on the basis of various 
reactions and mechanisms. 
1.6. Electrochemical Methods 
Electrochemical methods have been commonly used towards the development of 
numerous biosensors, the most famous of which is the glucose biosensor. 
Electrochemical analysis involves the measurement of current, potential or charge. The 
concentration and properties of the analyte, or the properties of the material used to make 
the electrode can be reflected by these measurements. Basic electrochemical methods 
involve: voltammetry and amperometry. Variations of these methods such as cyclic 
voltammetry, linear sweep voltammetry, square wave voltammetry and constant potential 
amperometry are selected to suit the specific application.  
1.6.1. Amperometry 
Amperometry can be defined as the measurement of a steady-state current in an 
electrolytic cell which is due to the oxidation or reduction of the analyte species. There 
may be no applied potential (galvanic cell) or there may be an applied potential. In this 
later case, a limiting current is established which is proportional to the concentration of 
the analyte.  
Consider a solution containing the analyte, A, in the presence of some conductive buffer. 
If an electrolytic potential is applied to the solution through a working electrode, then the 
measured current depends (in part) on the concentration of the analyte. Measurement of 
this current can be used to determine the concentration of the analyte directly; this is a 
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form of amperometry. However, the difficulty is that the measured current depends on 
several other variables, and it is not always possible to control all of them adequately. 
This limits the precision of direct amperometry. If the potential applied to the working 
electrode is sufficient to reduce the analyte, then the concentration of analyte close to the 
working electrode will decrease. More of the analyte will slowly diffuse into the volume 
of solution close to the working electrode, restoring the concentration. If the potential 
applied to the working electrode is great enough (an overpotential), then the 
concentration of analyte next to the working electrode will depend entirely on the rate of 
diffusion. In such a case, the current is said to be diffusion limited. As the analyte is 
reduced at the working electrode, the concentration of the analyte in the whole solution 
will very slowly decrease; this depends on the size of the working electrode compared to 
the volume of the solution.  
1.6.2. Voltammetry 
The common characteristic of all voltammetric techniques is that they involve the 
application of a potential (E) to an electrode and the monitoring of the resulting current 
(i) flowing through the electrochemical cell. In many cases the applied potential is varied 
or the current is monitored over a period of time (t). Thus, all voltammetric techniques 
can be described as some function of E, i, and t. They are considered active techniques 
(as opposed to passive techniques such as potentiometry) because the applied potential 
forces a change in the concentration of an electroactive species at the electrode surface by 
electrochemically reducing or oxidizing it. The analytical advantages of the various 
voltammetric techniques include excellent sensitivity with a very large useful linear 
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concentration range for both inorganic and organic species (10–12 to 10–1 M), a large 
number of useful solvents and electrolytes, a wide range of temperatures, rapid analysis 
times (seconds), simultaneous determination of several analytes, the ability to determine 
kinetic and mechanistic parameters, a well-developed theory and thus the ability to 
reasonably estimate the values of unknown parameters, and the ease with which different 
potential waveforms can be generated and small currents measured. 
 
1.6.3 Linear sweep voltammetry / Cyclic voltammetry 
In linear sweep voltammetry (LSV) a fixed potential range is employed much like 
potential step measurements. However in LSV the voltage is scanned from a lower limit 
to an upper limit as shown below. The characteristics of the linear sweep voltammogram 
depend on a number of factors including: 
• The rate of the electron transfer reaction(s) 
• The chemical reactivity of the electroactive species 
• The voltage scan rate 
In LSV measurements the current response is plotted as a function of voltage rather than 
time, unlike potential step measurements. The scan begins from the left hand side of the 
current/voltage plot where no current flows. As the voltage is swept further to the right 
(to more reductive values) a current begins to flow and eventually reaches a peak before 
dropping. To rationalize this behavior we need to consider the influence of voltage on the 
equilibrium established at the electrode surface. Here the rate of electron transfer is fast 
in comparison to the voltage sweep rate. Therefore at the electrode surface equilibrium is 
established identical to that predicted by thermodynamics. The exact form of the 
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voltammogram can be rationalized by considering the voltage and mass transport effects. 
As the voltage is initially swept from V1 the equilibrium at the surface begins to alter and 
the current begins to flow. The current rises as the voltage is swept further from its initial 
value as the equilibrium position is shifted further to the right hand side, thus converting 
more reactant. The peak occurs, since at some point the diffusion layer has grown 
sufficiently above the electrode so that the flux of reactant to the electrode is not fast 
enough to satisfy that required by the Nernst equation. In this situation the current begins 
to drop just as it did in the potential step measurements. In fact the drop in current 
follows the same behavior as that predicted by the Cottrell equation. The above 
voltammogram was recorded at a single scan rate. If the scan rate is altered the current 
response also changes. Each curve has the same form but it is apparent that the total 
current increases with increasing scan rate. This again can be rationalized by considering 
the size of the diffusion layer and the time taken to record the scan. Clearly the linear 
sweep voltammogram will take longer to record as the scan rate is decreased. Therefore 
the size of the diffusion layer above the electrode surface will be different depending 
upon the voltage scan rate used. In a slow voltage scan the diffusion layer will grow 
much further from the electrode in comparison to a fast scan. Consequently the flux to the 
electrode surface is considerably smaller at slow scan rates than it is at faster rates. As the 
current is proportional to the flux towards the electrode the magnitude of the current will 
be lower at slow scan rates and higher at high rates. 
Cyclic voltammetry (CV) is very similar to LSV. In this case the voltage is swept 
between two values at a fixed rate, however now when the voltage reaches V2 the scan is 
reversed and the voltage is swept back to V1. A typical cyclic voltammogram recorded 
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for a reversible single electrode transfer reaction is shown in below. Again the solution 
contains only a single electrochemical reactant. The forward sweep produces an identical 
response to that seen for the LSV experiment. When the scan is reversed we simply move 
back through the equilibrium positions gradually converting electrolysis product (Fe2+ 
back to reactant Fe3+). The current flow is now from the solution species back to the 
electrode and so occurs in the opposite sense to the forward seep but otherwise the 
behavior can be explained in an identical manner. For a reversible electrochemical 
reaction the CV recorded has certain well defined characteristics such as: 
1. The voltage separation between the current peaks is ± 59 mV. 
2. The positions of peak voltage do not alter as a function of voltage scan rate. 
3. The ratio of the peak currents is equal to one 
4. The peak currents are proportional to the square root of the scan rate 
The Randles-Sevcik equation can be used to predict the peak current obtained from a 
reversible redox reaction: 
ip = (2.69 x 105) n 3/2 ACD1/2v1/2     (1.3) 
where ip is current maximum in amperes, n = number of electrons transferred in the redox 
event,  A = electrode area in cm2,  F = Faraday’s Constant in C mol−1, D = diffusion 
coefficient in cm2/s, C = concentration in mol/cm3, ν = scan rate in V/s. 
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Figure 1.2. Voltage applied between working and counter electrode with respect to time and the current 
response measured at the working electrode during LSV.  
 
 
Figure 1.3. Voltage applied between the working and counter electrodes and current response measured at 
the working electrode during CV.  
 
1.6.4. Square wave voltammetry (SWV) 
The excitation signal in SWV consists of a symmetrical square-wave pulse superimposed 
on a staircase waveform of step height E, where the forward pulse of the square wave 
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coincides with the staircase step. The net current is obtained by taking the difference 
between the forward and reverse currents and is centered on the redox potential. The peak 
height is directly proportional to the concentration of the electroactive species and direct 
detection limits as low as 10–8 M are possible. SWV has several advantages. Among these 
are its excellent sensitivity, rejection of background currents and speed of analysis. This 
speed, coupled with computer control and signal averaging, allows for experiments to be 
performed repetitively and increases the signal to noise ratio. Applications of SWV 
include the study of electrode kinetics with regard to preceding, following, or catalytic 
homogeneous chemical reactions, determination of some species at trace levels, and its 
use with electrochemical detection in HPLC.  
 
Figure 1.4. Square wave voltammetry potential sweep.  
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1.6.5. Constant potential amperometry (CPA) 
CPA is an electrochemical technique where a constant potential is applied to a sensor 
(working electrode) and the faradaic current is measured. This current is generated by the 
reduction or oxidation of a chemical substance the electrode surface. The advantage of 
this technique is that the time resolution is limited only by the data collection frequency 
of the instrument. On the other hand, the primary disadvantage is the low chemical 
selectivity. For example, all species with oxidation potentials below the applied voltage 
will be oxidized and contribute to the current. 
 
1.7. Carbon fiber microelectrodes 
Carbonaceous electrodes have been used for several decades to detect various biological 
analytes due to their high electric conductivity, stable background currents, high signal to 
noise ratio and signal reproducibility (Kinoshita, 1998). Carbonaceous materials such as 
glassy carbon, carbon paste, carbon fibers, graphite and porous carbon have been 
employed for several years as electrochemical transducers. Recently, novel materials 
such as carbon nanotubes, graphene, carbon nanospheres are have been garnering 
attention due to unique electrochemical and mechanical properties (Qureshi et al., 2009). 
Carbon fiber microelectrodes were introduced by Pujol et al. nearly 30 years ago, who 
used them with normal pulse polarography to measure the oxidation of several 
neurotransmitters, including dopamine, norepinephrine and serotonin (Ponchon et al., 
1979). Since then, the most popular applications for carbon fiber electrodes have been as 
sensors for in-vivo detection of neurotransmitters. Carbon fiber microelectrodes have 
been used for biological applications due to advantages such as:  
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• Excellent biocompatibility and non-toxicity towards cells.  
• Good electrochemical properties which have been extensively studied and 
characterized.  
• Miniature size (<10μm in diameter) of electrodes makes them ideal for 
implantation with minimal damage.  
• Carbon fiber microelectrodes enable rapid measurements when used with fast 
electrochemical techniques such as amperometry, chronoamperometry and fast 
scan cyclic voltammetry.  
Carbon fiber microelectrodes and electrochemistry have been established as a standard 
technique to monitor numerous neurotransmitters such as dopamine, serotonin, 
epinephrine, norepinephrine, etc (Troyer et al., 2002; Heien et al., 2004). Thus carbon 
fiber microelectrodes have enabled scientists to map the neurochemical activity of the 
brain related to disorders such as epilepsy, Huntington’s disease, Parkinson’s disease, 
Tourette syndrome, depression, etc (Pacia et al., 2001; Sidlo et al., 2008). Carbon fiber 
microelectrodes have also been used to test the pharmacodynamics of drugs in in-vivo 
models. Another interesting application of carbon fiber microelectrodes was developed 
by Wightman and his colleagues by placing a carbon fiber microelectrode with a 5 μm 
diameter at micrometer distances from a living adrenal chromaffin cell; they were able to 
monitor exocytosis in real time (Leszczyszyn et al., 1990; Wightman et al., 1991). 
Although estranged from their indigenous surroundings, individual isolated or cultured 
cells can sustain their characteristic metabolic and neuro(physiological) processes. Thus 
single cells can act as good experimental models for examining complex biological 
processes and functions in a controlled straightforward manner. Thus single and array 
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microelectrodes have been used to measure neurotransmitter, nitric oxide, reactive 
oxygen species release from single cells (Schulte and Schuhmann, 2007). 
 
Figure 1.5. Schematic representation of carbon fiber microelectrode components. 
 
Figure 1.6. Actual photograph of carbon fiber microelectrode to appreciate size.  
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Chapter 2 
Amperometric micro-immunosensor for the detection of tumor biomarker 
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2.1.  Introduction 
 
VEGF is an important angiogenic factor that plays a crucial role in tumor growth and 
metastasis. It is a homodimeric glycoprotein produced by endothelial cells and binds to a 
protein receptor in the endothelium vessels, initiating a signaling cascade that ultimately 
results in angiogenesis (Kranz et al., 1999) (Kurebayashi et al., 1999) (Ruohola et al., 
1999) (Zhai et al., 1999). VEGF production is increased by tumor cells in response to 
stimuli such as hypoxia, abnormal gene activity and activation of other receptors and 
pathways in tumor cells. VEGF is overexpressed in a vast majority of human tumors 
including lung, thyroid, breast, gastrointestinal tract, kidney, bladder, ovary, etc. Tumor 
secreted VEGF initially accumulates on the tumor endothelium (Ferrara and Davis-
Smyth, 1997).  VEGF levels on cell surface and in serum can thus be used as a predictive 
factor for malignancy. Furthermore, patients with VEGF-positive tumors have been 
shown to have a worse prognosis and early relapse compared to those with VEGF-
negative tumors (Masakazu Toi, 1994) (Maeda et al., 1996).  
The current techniques used for VEGF quantification include 
immunohistochemistry, enzyme linked immunosorbent assays (ELISA), 
radioimmunoassay, Western blot, etc. However all these techniques are labor-intensive, 
time consuming, require highly trained personnel or expensive equipment. Therefore, 
there is a need to develop a suitable detection strategy to carry out real-time, direct, 
sensitive analysis of VEGF. The development of a direct, real time detection protocol for 
VEGF would enable monitoring serum VEGF levels in patients during therapy to 
determine efficacy.  
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Detection of biomolecules has been of significant interest in areas such as 
genomics, proteomics, medical diagnostics and environmental monitoring. Optical, 
mechanical, magnetic and electrochemical sensors have been at the forefront of 
biomolecular detection. Electrochemical biosensors have attracted substantial research 
efforts due to their high sensitivity, selectivity, miniaturization, low cost, and ease of 
operation.  They have been used for detecting small amounts of hormones, enzymes, 
viruses, tumor antigens, DNA mutants and bacterial antigens (Privett et al., 2008). All 
electrochemical biosensors are based on a two component system, which include a 
biological recognition element and a signal conversion unit (Leland C. Clark Jr, 1962). 
Electrochemical immunosensors use antibodies as their biorecognition elements. 
Antibodies offer numerous advantages such as high specificity, versatility, and good 
stability. Electrochemical immunosensors operate by measuring either current 
(amperometric), potential difference (potentiometric) or capacitance. The measurement of 
current is the most common and convenient method used to detect biomolecules. 
Amperometric immunosensors can be classified into two different types, as direct and 
indirect. Direct immunosensors can be used to detect proteins exhibiting electroactive 
amino acids such as tyrosine (Tyr) and tryptophan (Trp) or a metal center with reversible 
redox-activity (metalloproteins) (Reynaud et al., 1980, Brabec and Schindlerova, 1981, 
Okuno et al., 2007, Armstrong, 1990). However most biomolecules are not electroactive, 
hence redox tags are required to enhance their detection. For the detection of non-
electroactive VEGF, ferrocene was chosen as an electrochemical tag due to its special  
properties such good stability, and easy chemical modification, (Zhang et al., 2008).  
When an appropriate potential is applied ferrocene is easily detectable using voltammetry 
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as it rapidly oxidizes without the formation of intermediate products. Zhang et al., 
developed a highly sensitive immunoassay strategy based on the combination of 
ferrocene label and poly(o-phenylenediamine) film/gold nanoparticle amplification using 
IgG (Immunoglobulin) as the model analyte (Zhang et al., 2008).  Akram et al,(Akram et 
al., 2006) quantified human chorionic gonadotrophin in clinical samples by measuring 
the oxidation of ferrocene linked to a secondary antibody. Ferrocene was used for the 
detection of hemoglobin A1c and human chorionic gonadotrophin using flow 
immunoassay systems (Tanaka et al., 2007, Lim and Matsunaga, 2001). Ferrocene linked 
oligonucleotide conjugates have also been used for the electrochemical study of DNA 
and detection of DNA mutants (Ihara et al., 1996) (Nakayama et al., 2002). 
The sensing platform employed in the presented work is composed of carbon fiber 
microelectrodes which offer advantages such as extremely high sensitivity due to high 
signal-noise ratio, enhanced mass transport, and reduced ohmic drop. In addition, the use 
of microelectrodes opens up the possibility of in vivo electrical sensing of various 
biological compounds in living cells and tissue cultures.  Furthermore, the miniaturized 
size of the electrode allows the careful selection of the cell or matrix to be investigated 
with negligible physical damage to the implanted region.  In this regard, the use of a 
micro sized electrode also offers a non-destructive way of highly sensitive analysis.  
In the present work, we describe a reagentless, electrochemical immunosensing 
strategy for an enhanced detection of immunospecies based on the direct oxidation of 
ferrocene label. We describe the fabrication of disk shaped carbon fiber microelectrodes 
which are immobilized with ferrocene labeled anti-VEGF antibody using a Jeffamine 
cross-linker. Upon incubation of these electrodes with VEGF solution, the formation of 
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immunocomplexes, leads to a decrease in the electrochemical response of ferrocene due 
to increased spatial blocking. This alteration in the electrode response induced by 
interfacial immunoreactions was employed to quantify the amount of VEGF. Using the 
proposed immunosensing strategy, VEGF could be detected specifically with a low 
detection limit and a wide linear dynamic range. The experimental conditions were 
optimized, and the performance features such as stability and specificity were also 
evaluated. Thus we describe a one-step immunosensing format for the direct detection of 
target analytes.   
 
2.2. Experimental 
 
2.2.1. Materials 
Carbon fibers (5 μm in dia.) were donated by World Precision Instruments (Sarasota, 
FL).   Anti-Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor, 2-
Allylphenol, liquefied phenol (90%), and butyl cellosolve (2-butoxyethanol), reagent 
grade methanol, Jeffamine® ED-600, potassium ferrocyanide, potassium ferricyanide, 
were purchased from Sigma Aldrich (St. Louis, MO). Borosilicate glass capillaries (outer 
dia. 0.5mm, inner dia 0.3mm) were obtained from Sutter Instrument Company (Novato, 
CA). Ferrocene monocarboxylic acid min. 97%, EDC (1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride) 98%, sodium perchlorate (NaClO4) 
(anhydrous) and Na-HEPES [sodium 4-(2-hydroxyethyl)-1-piperazineethanesulfonate] 
were purchased from Fisher Scientific (Pittsburgh, PA). Sylgard 184 was obtained from 
Dow Corning Corporation (Midland, MI).    
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2.2.2. Instrumentation    
Carbon fiber microelectrodes were prepared using P-97 micropipette Puller (Sutter 
Instrument Company, Novato, CA).  Ferrocene monocarboxylic acid solution filtration 
was carried using the Millex-GS (Syringe driven filtration unit, 0.22 μm). Anti-VEGF 
was concentrated using the Microcon (Ultracel YM-50, 50 kDa) purchased from Millpore 
Corporation (Bedford, MA). Scanning electron microscopy (SEM) was carried out on the 
JEOL JSM 5900LV. Electrochemical measurements were carried out using CHI-630A 
electrochemical analyzer (CH Instruments, Inc., Austin, TX). A conventional three 
electrode cell consisting of an Ag/AgCl reference electrode (3 M KCl) (Bioanalytical 
Systems, IN, USA), and a platinum wire as an auxiliary electrode was employed.  
 
2.2.3. Preparation of micro immunosensor  
2.2.3.1. Fabrication of disk-shaped carbon fiber microelectrodes 
Carbon fiber microelectrodes were fabricated by following the method described by Ates 
et al. (Ates et al., 2008). Briefly, a single carbon fiber of diameter 5 μm was attached to 
the stripped end of an insulated copper wire (dia. 0.2 mm) using a silver conductive paste. 
The silver paste was allowed to dry, after which the free end of the copper wire was 
cannulated into a borosilicate glass capillary. The copper wire was fixed to the capillary 
using a fast drying epoxy resin. The capillary was then pulled using a micropipette puller. 
This pulling procedure results in two glass pipettes, one of which is discarded, and the 
other which holds the carbon fiber protruding from its tip. The junction between the 
carbon fiber and capillary is sealed with a drop of the Sylgard silicone preparation and 
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allowed to cure until it becomes firm. The protruding fiber was trimmed to a length of 
2mm. 
 
2.2.3.2. Insulation of carbon fiber microelectrodes 
Carbon fiber microelectrodes were insulated according to the procedure described by 
Strein and Ewing (Strein and Ewing, 1992). Briefly, Carbon fibers were insulated using 
electropolymerisation of allylphenol in a solution containing 90 mM 2-allylphenol and 
60mM phenol. A constant potential of 4.0 V was applied to the carbon fiber 
microelectrode vs. a platinum wire counter/reference for a period 14 to 16 minutes. The 
polymer coating was then cured by placing the electrodes in an oven at 150 oC for 30 
minutes. 
 
2.2.3.3. Preparation of the ferrocene linked anti-VEGF (Fc-anti-VEGF) 
The conjugation of ferrocene monocarboxylic to anti-VEGF is carried out as described by 
Lim and Matsunaga (Lim and Matsunaga, 2001). Briefly, 4 mg of ferrocene 
monocarboxylic acid was dissolved in 800 µl of Na-HEPES buffer (0.15 M, pH 7.3) and 
filtered through a 0.22 μm pore filter. 10 mg of EDC and 90 µl of 500 µg/mL anti-VEGF 
were then added to this filtered solution and incubated for 4 hours at room temperature. 
Removal of unlabeled ferrocene was carried out using ultrafiltration with a Centricon 
YM-30 filtration device. After each filtration step the filtrate was collected and analyzed 
using UV-Vis spectroscopy. Ultrafiltration was conducted until the peak corresponding to 
ferrocene disappeared from the spectra of the filtrate solution (Mina Okochi, 2005). 
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2.2.3.4. Modification of carbon fiber microelectrode surface 
Fc-anti-VEGF immobilization was carried out by coupling the carboxylic acid (-COOH) 
groups found on the carbon fiber to the C terminal of the antibody via a bifunctional 
linker molecule (Jeffamine® ED-600).  This modification resulted in a stable monolayer 
of Fc-anti-VEGF on the carbon fiber surface. 
 
2.2.3.4.1 Activation of carbon fiber surface 
Carboxyl groups on the carbon fiber surface were activated by reacting with 4 mg/mL of 
EDC in phosphate buffer (0.15 M NaCI, 0.10 M Na2HP04, pH 7.4) for 12 hours.  
 
2.2.3.4.2. Attachment of Fc-anti-VEGF to carbon fiber surface 
The electrodes were then dipped into a 0.4 mM solution of Jeffamine ED-600 in aqueous 
buffer for 30 minutes. This attaches the hydrophilic spacer arm of Jeffamine to the 
electrode surface via an amide bond. Following a buffer wash, the electrodes were then 
placed in Fc-anti-VEGF solution for 5 hours at 4 oC. The carboxylic groups present on 
the anti-VEGF antibody form amide bonds with the free terminal amines on the surface-
bound Jeffamine molecules (Pantano et al., 1991). Thus two amide bonds formed on each 
end of the linker molecule assist in the immobilization of anti-VEGF on the carbon fiber 
microelectrode surface. Covalent coupling is always preferred as it provides a more 
stable and permanent binding of biological materials to the substrate. In the process of 
immobilized antibody-antigen molecular recognition, the orientation of the immobilized 
antibody and the accessibility of the antigen dictate the interaction between antibody and 
antigen. The use of a linker molecule for immobilization has been shown to considerably 
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improve both these factors. Jeffamine ED-600 was found to have an optimal length that 
resulted in the highest binding efficiency and increase in bio-affinity of immobilized 
antibodies (Cao et al., 2007). 
 
2.3. Results and discussions 
 
2.3.1. Characterization of disk shaped Carbon fiber microelectrodes  
 
2.3.1.1 Surface characterization using SEM 
Controlling the electroactive surface area of the microelectrodes was a crucial parameter 
to achieve reliability and reproducibility. Uncoated cylindrical carbon fibers could not be 
used as it is difficult to control the area of the fiber in contact with the electrolyte during 
each measurement. Disk shaped microelectrodes fulfilled this requirement as they are 
fully insulated and only a uniform circular area corresponding to their diameter is 
electroactive. Carbon fiber microelectrodes were fabricated and properly sealed prior to 
being insulated by electropolymerisation using a phenol-allylphenol copolymer. The 
insulated carbon fibers were then transected using a scalpel blade under a dissecting 
microscope to reveal a disk shaped electroactive area. From the SEM images of the disk 
shaped microelectrode shown in figure 2.1. it is evident that the insulating layer is well 
formed and only the tip of the carbon fiber is exposed.  
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Figure 2.1. SEM images of phenol-allylphenol copolymer insulated disk shaped carbon fiber 
microelectrodes. 
 
2.3.1.2. Electrochemical characterization 
Cyclic voltammetry was performed in 0.03M Fe(CN)6-3/-4 before and after microelectrode 
insulation.  From figure 2.2 it is evident that before insulation the electroactive area of 
each electrode varies however after insulation the electrodes behave in a similar pattern. 
The effective radii Reff of these electrodes can be determined from the limiting plateau 
currents (Ilim) according to the following equation (Huang and Kennedy, 1995, Zhang et 
al., 1999). 
Ilim= 2πnFDCReff   (2.1) 
In the above equation,  ‘n’ is the number of electrons transferred during the 
electrochemical process, ‘F’ is Faraday constant, while ‘D’ and ‘C’ are the diffusion 
coefficient and concentration of the electroactive species, respectively. By using the 
known value of the diffusion coefficient of potassium ferricyanide, 7.2×10−6 cm2/s, 
(Albillos et al., 1997) the average Reff for the microelectrodes was calculated to be 
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approximately 5µm. Carbon fiber microelectrodes with similar surface area were chosen 
for further work. 
 
Figure 2.2.A. Cyclic voltammograms of 3 non-insulated carbon fiber microelectrodes. Measurements were 
taken in 0.03 mol/L potassium ferricyanide solution. Scan rate was 0.1 V/s and potential limits were from   
-1.0 V to +0.4 V vs. Ag/AgCl reference electrode 
 
Figure 2.2.B. Cyclic voltammograms of phenol-allylphenol insulated (disk shaped) carbon fiber 
microelectrodes. Measurements were taken in 0.03 mol/L potassium ferricyanide solution. Scan rate was 
0.1 V/s and potential limits were from   -0.4 V to +0.4 V vs. Ag/AgCl reference electrode 
 
2.3.2. Molecular Assembly of Immunosensor 
This work has been directed towards developing a reagentless, electrochemical 
immunosensor for the detection of VEGF. The general molecular assembly of the 
immunosensor is depicted in figure 2.3. To construct the immunosensor carbon fiber 
microelectrodes were used as the sensing platform. Ferrocene tagged anti-VEGF 
antibodies were immobilized on the microelectrode surface using a Jeffamine linker. 
Covalent attachment of antibody using Jeffamine linker enables covalent attachment 
which offers higher stability than physical adsorption methods. Covalent attachment also 
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enables better control of antibody orientation, which has been proven to play a key role in 
immunosensor performance. Direct oxidation of ferrocene tagged on anti-VEGF which is 
attached to the carbon fiber surface gives a measurable signal. The formation of VEGF 
and anti-VEGF immunocomplexes leads to spatial blocking and a drop in measured 
current. In our work, linear sweep voltammetry for the oxidation of ferrocene 
monocarboxylic acid was performed before and after incubation of VEGF with 
immunosensor, so that the resultant drop in oxidation peak current could be related to the 
amount of VEGF present in sample solution. Traditionally, sandwich formats which 
include two antibodies, one to capture the analyte and the other to provide a measurable 
signal have been used to create immunosensors.  We describe a direct detection method 
in which a single antibody tagged using ferrocene performs both the functions of analyte 
capture and signaling, enabling a one-step detection platform. The voltammetric 
performance of the micro immunosensor is directly influenced by the parameters 
involved in its preparation. The incubation time and amount of anti-VEGF immobilized 
on the surface are two crucial parameters. Experiments were performed in order to 
evaluate and optimize the above mentioned parameters.    
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Figure 2.3. A schematic representing the molecular architecture and working of a micro immunosensor. 
 
2.3.3. Optimization of immobilization conditions 
 
2.3.3.1. Effect of incubation time 
The incubation time required for the antigen-antibody immunoreaction is an important 
parameter that determines the performance of an immunosensor. Hence, we conducted 
experiments to optimize the incubation time. An Fc-anti-VEGF modified carbon fiber 
microelectrode was incubated with 5 µL of 200 pg/ml VEGF solution. Linear sweep 
voltammetry was then performed in a 0.5 M NaClO4 solution at 10 minute intervals. 
From figure 2.4. it is evident that the oxidation peak current keeps decreasing gradually 
with the augment of incubation time. After about 40 minutes the peak current stabilizes, 
which indicates saturated formation of immunocomplex. Hence an incubation time of 40 
minutes was chosen for all further experiments to allow completeness of the 
immunoreactions. 
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Figure 2.4. Fc-anti-VEGF modified carbon fiber microelectrode incubated with a 200 pg/ml VEGF 
solution. Linear Sweep Voltammetry was performed in 0.5 M NaClO4 solution (vs. Ag/AgCl) every 10 
minutes. Oxidation peak current is plotted versus responding incubation time.  
     
2.3.3.2. Amount of anti-VEGF immobilized carbon fiber microelectrode surface   
To evaluate the amount of ferrocene labeled antibody immobilized on the surface of 
carbon fiber microelectrode we rely on the resulting oxidation current from Fc-anti-
VEGF modified electrode. Linear sweep voltammetry was performed in a 0.5 M NaClO4 
solution at a scan rate of 0.75 V/s. In these experiments, 10 carbon fiber microelectrodes 
activated using EDC were incubated with different concentrations of Fc-anti-VEGF 
solution for about 5 hours at 4 oC. The oxidation current obtained for each of the 
electrodes were plotted against the corresponding concentration of the Fc-anti-VEGF 
solution with which it was incubated. We observe from figure 2.5. that enhanced binding 
of the antibody to the electrode surface was observed during the concentration range of 
50- 750 pg/ml. The binding efficiency leveled off for the concentration of 800 pg/ml and 
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higher. Hence, for all further immobilization experiments the ferrocene labeled anti-
VEGF concentration used was 800 pg/ml.  
 To quantify the amount of ferrocene labeled anti-VEGF immobilized on carbon fiber 
microelectrode surface we use the following equation:  
Ip=n2F2νAҐ / 4RT  (2.2) 
where ‘Ip’ is the peak current, ‘n’ is the number of electrons transferred during the 
electrochemical process, ‘F’ is Faraday constant, ‘ν’ is the scan rate in V/s, ‘Ґ’ is surface 
coverage in mol/cm2, ‘R’ is the Universal Gas constant and ‘T’ is temperature in oK. 
Cyclic voltammetry performed in 0.5 M NaClO4 solution with a scan rate of 0.75 V/s, 
using an Fc-anti-VEGF modified Carbon fiber microelectrode revealed an oxidation peak 
current of 20.4 pA. Using these values in equation (2.2) we obtained surface coverage 
values of ferrocene to be 33.3 X 10-7 mol/cm2. To calculate the surface coverage of anti-
VEGF from that of ferrocene we have to consider that, approximately 12 ferrocene 
moieties are attached to each anti-VEGF molecule. Hence the surface coverage of anti-
VEGF is calculated to be 2.78 X 10-8 mol / cm2.  
 
 
38 
 
Figure 2.5. Three activated Carbon fiber microelectrodes were incubated with 5 µL of PBS buffer, 50, 150, 
300, 400, 750, 800, 850, 1000, 1100 pg/ml solutions of Fc-anti-VEGF solutions. Cyclic voltammetry was 
performed in 0.5 M NaClO4 solution (vs. Ag/AgCl) after 5 hours. The average value of peak oxidation 
current obtained from three microelectrodes is plotted versus the concentration of the antibody solution. 
 
2.3.4. Electrochemical Characterization of Fc-anti-VEGF modified Carbon fiber 
microelectrodes. 
 The voltammetric behavior of Fc-anti-VEGF was studied at different scan rates (0.1 to 
0.75 V/s) as shown in figure 2.6. All the voltammograms recorded at different scan rates 
exhibited well-defined, symmetrical oxidation and reduction peaks. The oxidation peak 
for free ferrocene monocarboxylic acid appears at 0.395 V versus Ag/AgCl (Tanaka et 
al., 2007). In our case the anti-VEGF bound ferrocene displays an oxidation peak at 0.52 
V versus Ag/AgCl. The shift in peak potential is due to the chemical conjugation of anti-
VEGF to the carboxylic acid of ferrocene. The redox potential of ferrocene derivatives 
depends on the functional groups present in the side chain (Padeste et al., 2000). Both the 
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oxidation and reduction peak currents increased linearly with scan rates (figure 2.7.), 
which indicates that the Fc always remains on the electrode retaining its electrochemical 
activity. The oxidation and reduction peak currents were almost equal, and the potential 
difference between the peaks was constant with increase of scan rates showing that the 
electron transfer between the ferrocene moieties and carbon fiber microelectrode surface 
was relatively fast, indicating a surface controlled process (Zhang et al., 2007). 
 
Figure 2.6. Cyclic Voltammograms of Fc-anti-VEFG modified Carbon fiber microelectrode measured in 
0.5 M NaClO4, with scan rates of 0.1, 0.2, 0.3,0.4, 0.5, and 0.75 V/s. 
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Figure 2.7. Anodic and Cathodic peak current of Fc-anti-VEGF modified carbon fiber microelectrode in 0.5 
M NaClO4 electrolyte. 
 
2.3.5 Detection of VEGF 
The micro-immunosensors designed as aforementioned were then incubated with 10 
pg/ml to 110 pg/ml solutions of VEGF at room temperature. After incubating the sensor 
with sample solutions for a period of 40 minutes, electrochemical measurements were 
carried out in a 0.5 M NaClO4 solution at a 0.75 V/s scan rate. From Fig. 2.8., we observe 
that when we move from A-J the magnitude of the oxidation current decreases. This 
decrease in peak current with increase in VEGF concentration can be attributed to the 
increased spatial blocking caused due to the formation of immunocomplexes. The 
immunoreactions between VEGF and anti-VEGF causes a blockage to the flow of 
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electrons coming from the ferrocene molecules attached to the antibody and traveling to 
the carbon fiber sensor surface (Wu et al., 2008). From this observation it is evident that a 
fall in peak current is inversely proportional to VEGF concentration in solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8. Linear sweep voltammetry responses of Fc-anti-VEGF modified carbon fiber microelectrode to 
VEGF at different concentrations. All measurements were performed in 0.5 M NaClO4 versus Ag/AgCl.          
 
A calibration curve obtained by plotting change in peak current (Δ Ipeak) against the 
concentration of VEGF is shown in figure 2.9. Based on the plot the sensitivity and 
detection limit were found to be 2.047 pA pg/ml and 38 pg/ml, respectively.   
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Figure 2.9. Calibration Curve: The linear relationship between change of current response and VEGF 
concentration. 
 
2.3.6 Evaluation of electrode stability 
We have evaluated the stability of the electrodes over a period of one month. The micro-
immunoelectrodes were stored in 0.1 M PBS buffer solution at 4 oC after fabrication. 
Stability of the designed electrodes was studied by incubating them with 50 pg/ml of 
VEGF. Cyclic voltammetry was performed every day before and after incubation. The 
activity of the immunosensors was evaluated by measuring the drop in peak current after 
incubation. Up to the 24th day the drop in peak current corresponded to the drop expected 
for 50 pg/ml of VEGF. From then onwards the activity of the immunosensors kept 
declining. This trend suggests that the designed electrodes are suitable for VEGF analysis 
up to 24 days.  
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2.3.7 Specificity Studies  
Specificity is a crucial parameter which influences the performance of an immunosensor 
in real matrices. We need to prove that the presented sensor responds only to the VEGF 
and anti-VEGF immunoreaction and not to the nonspecific adsorption of other proteins. 
In order to demonstrate the specificity of our immunosensor we have incubated our 
electrodes with IgG and bovine serum albumin (BSA).  Four Fc-anti-VEGF modified 
carbon fiber microelectrodes were incubated for 40 minutes with 4 different sample 
solutions which include a) 50 pg/ml VEGF, b) 50 pg/ml IgG, c) 25 pg/ml VEGF + 25 
pg/ml IgG, and, d) 10 µg/ml BSA in 10mM PBS, respectively. Linear sweep 
voltammetry was performed before and after incubation for each electrode. Figure 2.10. 
shows drop in peak current after incubation with the sample solutions. It is evident that 
there a current drop proportional to the VEGF concentration for samples a and c. 
However, samples b and d show no significant changes in peak currents. Hence we can 
conclude that the obtained current change was caused due the immunoreactions of VEGF 
and anti-VEGF and the presence of other proteins seemed not to interfere with the sensor 
performance. 
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Figure 2.10. Drop in peak current of 4 Fc-anti-VEGF modified carbon fiber microelectrodes after being 
incubated with sample a (50 pg/ml VEGF), sample b (50 pg/ml IgG), sample c (25 pg/ml VEGF + 25 pg/ml 
IgG), and sample d (10 µg/ml BSA) in 10mM PBS respectively. Measurements were performed in 0.5 M 
NaClO4 versus Ag/AgCl. 
 
2.4. Conclusion 
In this work we have successfully designed and characterized a reagentless, miniaturized 
electrochemical immunosensing system for the rapid detection of VEGF.  In addition, 
this single use sensor requires no sample preparation for measurement of VEGF in 
patient fluid samples. The detection mechanism is based on the measurement of 
electrochemical signal changes induced by the interfacial immunoreactions of surface 
immobilized ferrocene linked anti-VEGF antibody probes with VEGF present in solution.  
A detection limit of about 38 pg/ml for VEGF is obtained in this work which is sufficient 
to detect VEGF in plasma of normal subject (138 pg/ml) and cancer patients (435-
445pg/ml) (Karayiannakis et al., 2002). Further, a similar detection strategy can be 
applied towards the detection of any non-electroactive biomolecules by using an 
appropriate antibody. Therefore the detection strategy is applicable towards most 
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biomolecules present in patient fluid samples and can be used to obtain diagnostic, 
prognostic or therapy response related information.  The limitations of the detection 
strategy are the long response time (45 minutes), need to redox probe (ferrocene) to 
provide an indirect measurement of biomarker binding, and single-use capabilities. In 
order to resolve these disadvantages a direct detection strategy was developed as 
described in Chapter 3. 
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Chapter 3 
Electrochemical Sensor for Multiplex detection of Amyloid Beta 40 and 42 for 
Alzheimer’s Disease Diagnostics 
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3.1. Introduction 
 
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases 
currently affecting about 5.3 million people in the United States alone (Herbert et al., 
2003). The national cost of caring for AD patients is ~ 100 billion each year. Despite 
important advances in the understanding of AD, much is still unknown about the 
underlying cause of the disease. Aβ peptide compries of 39-42 amino acids is the primary 
constituent of plaques found in the brain of patients suffering from AD. These insoluble 
plaques hinder the communication between neurons causing cell death, cognitive 
dysfunction, and behavioral abnormalities, they also initiate a host of other events 
including inflammation and tau aggregation as neurofibrillary tangles (Hardy and 
Higgins, 1992; Murphy and LeVine, 2010). However, till date there is no inexpensive, 
sensitive, real time detection strategy for monitoring Aβ in-vivo which can ultimately 
answer critical questions regarding its production, accumulation and clearance under 
physiological and patho-physiological scenarios. The growing potential of the Aβ ratio to 
act as a biomarker in diagnostic, prognostic, and therapeutic research studies warrants a 
better understanding of its biochemistry (Andreasen et al., 1999; Hampel et al., 2010; 
Blennow, 2004). There is still a significant amount of research required to completely 
understand the link between Aβ and the underlying cause of AD. Assessment of the 
interstitial and cerebrospinal pools of Aβ may provide unique insights into the regulation 
of Aβ aggregation and plaque formation (Bibl et al., 2007; Tampellini and Gunnar, 
2010). Studies of this nature have been previously performed in-vitro on neuronal cell 
cultures and brain slices using fluorescence microscopy and ELISA (Wyss-Coray et al., 
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2003). Towards in-vivo Aβ measurements, microdialysis has been the most commonly 
utilized technique for the past 10 years (Cirrito et al., 2005).  
This work has been directed towards the development of an electrochemical 
immunosensor capable of simultaneously detecting two Aβ isoforms using the intrinsic 
electroactivity of Aβ (Vestergaard et al., 2005). Aβ contains a single Tyr residue at 
position 10, bearing a phenolic group, which is easily oxidized at the electrode surface 
(Chikae et al., 2008). Carbon fiber microelectrodes were used as the platform sensor as 
they offer advantages such as high signal to noise ratio, biological compatibility, and 
miniature size (Armstrong-James and Millar, 1979). Carbon based electrodes have been 
proven to sensitively detect Tyr oxidation (Okuno et al., 2007; Kerman et al., 2006). 
Using SWV the voltage applied to the carbon fiber microelectrode was scanned within a 
window of -0.2 V to 1.0 V. The voltammogram shows increase/peak in measured current 
due to the oxidation of electroactive species, when the electrode attains the corresponding 
oxidation potential. When the electrode scans through 0.6 V, Tyr residues present in Aβ 
oxidize which causes up to 4 electrons/molecule to be released that are detected by the 
electrode as increased/peak current. While 0.6 V can cause oxidation of a variety of 
molecules, including all nearby tyrosines, an antibody covalently attached to the 
electrode surface can provide specificity for a particular target such as Aβ. By monitoring 
the intrinsic electrochemical activities of Aβ, direct, real-time, and reagentless detection 
is possible. 
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3.2. Materials and Methods 
 
Carbon fibers (5 μm in diameter) were donated by World Precision Instruments 
(Sarasota, FL). Borosilicate glass capillaries (3 barrels, inner diameter 1.0 mm) were 
obtained from Sutter Instrument Company (Novato, CA). Sylgard 184 was obtained from 
Dow Corning Corporation (Midland, MI). 1-ethyl-3-[3-dimethylaminopropyl] 
carbodiimide hydrochloride (EDC) and N-hydroxysulfosuccinimide (NHSS), EZ-Link 
Plus Activated Peroxidase was purchased from Thermo Fisher Scientific Inc. (Rockford, 
IL). Aβ antibodies (mHJ2, mHJ7.4, mHJ5.1) were donated by Dr. Cirrito’s laboratory. 
Aβ1-40 and Aβ1-42synthetic peptide were obtained from American Peptide Company 
(Sunnyvale, CA). MES buffer, 3,3′-diaminobenzidine (DAB), hydrogen peroxide (H2O2), 
sodium chloride, and other reagents were purchased from Sigma–Aldrich (St. Louis, 
MO). 
 
3.2.1. Instrumentation 
Carbon fiber microelectrodes were prepared using P-97 Micropipette Puller and BV-10 
Beveller acquired from Sutter Instrument Company (Novato, CA). Microelectrode 
activation and electrochemical measurements in connection with CV, differential pulse 
voltammetry (DPV) and SWV were carried out using the 600C Electrochemical Analyzer 
attached to a Picoamp Booster from CH Instruments, Inc. (Austin, TX). SEM of the triple 
barrel microelectrodes was carried out on the JEOL JSM 5900LV. The cyclic square 
wave E-field was applied using the Leader LFG-13005 function generator and monitored 
using the Lafayette-82418 oscilloscope. A conventional three electrode cell consisting of 
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an Ag/AgCl reference electrode (3 M KCl) (Bioanalytical Systems, IN, USA), and a 
platinum wire as an auxiliary electrode was employed. 
 
3.2.2. Fabrication of Triple Barrel Aβ1-40/Aβ1-42 Sensor 
Triple barrel carbon fiber microelectrodes were fabricated using the same method as 
described in our previous work. Briefly, a single carbon fiber of diameter 5 μm was 
attached to the stripped end of an insulated copper wire (diameter 0.2 mm) using a silver 
conductive paste. Each barrel of the borosilicate glass triple barrel capillary was then 
cannulated with a carbon fiber attached copper wire. The three copper wires were then 
fixed to the capillary using a fast drying epoxy resin. The capillary was then pulled using 
a micropipette puller. This pulling procedure results in two glass pipettes, one of which is 
discarded, and the other which holds three carbon fibers protruding from its tip. The 
junction between the carbon fibers and capillary is sealed with a drop of the Sylgard 
silicone preparation and allowed to cure until it becomes firm. The microelectrodes were 
then beveled at 45° using a diamond abrasive plate, to obtain three disk shaped electrodes 
which are completely isolated from each other. The surface of the electrodes was cleaned 
by 5 s sonication in acetone, 1 M nitric acid, 1 M KOH and distilled water sequentially. 
To facilitate the binding of capture antibody, the microelectrodes were electroactivated 
using a 150 mM NaCl solution (pH=10) at 1.2 V (vs. Ag/AgCl) for 8 minutes at room 
temperature. 0.4 M of EDC and 0.1 M of NHSS solutions in 0.1 M MES buffer (pH=6) 
were then sequentially applied for 20 minutes to activate the carboxylic groups on the 
carbon fiber surface by forming a semi stable amine reactive NHS ester. The 
microelectrodes were then placed sequentially in mHJ2 (specific to Aβ1-40) (E1(40)), 
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mHJ7.4 (specific to Aβ1-42) (E2(42)), and mHJ5.1 (specific to all isoforms of Aβ) 
(E3(TOT)) antibody solutions and a cyclic square wave E-field (–0.3 V to +0.3 V, 0.1 
Hz, 10 minutes) was applied sequentially to each electrode versus a platinum wire 
cathode. Application of the E-field allows for the selective placement of mHJ2 on E1, 
mHJ7.4 on E2(42) and mHJ5.1 on E3(TOT). Electrodes were incubated in 0.1 % 
ethanolamine solution to block any non-specific binding sites. In order to obtain 
quantitative measurements about the amount of antibody conjugated to the electrode, 
horseradish peroxide (HRP) labeled antibodies were utilized. Labeling of Aβ antibody 
(mHJ5.1) to HRP was performed as per protocol specified by Thermo Scientific. DAB 
and H2O2 were used as the substrates in HRP catalysis reaction and measurements were 
conducted using DPV (Zhang et al., 2008). Crucial parameters related to efficient 
antibody immobilization such as antibody solution concentration, E-field parameters, and 
immobilization time were optimized based on the HRP based electrochemical results.  
 
3.2.3. Measurement of Aβ1-40 and Aβ1-42 in cerebrospinal fluid (CSF) solutions 
Aforementioned micro-immunosensors were then challenged using rat CSF solutions 
spiked with different combinations of Aβ1-40 and Aβ1-42 within a range of 10 nM to 2 
μM. A cyclic square wave E-field (+0.75 to -0.75 V, 50 Hz, 10 minutes) was applied 
simultaneously to each of the three electrodes in order to accelerate the incubation 
process. The electrodes were rinsed twice with PBS buffer (pH = 7.2) to get rid of any 
randomly or loosely attached Aβ molecules. SWV was used to simultaneously evaluate 
the response of each of the three microelectrodes before and after the 
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immunoreactions.SWV voltammetry was performed using 10 mM PBS and 1 mM KCl as 
the supporting electrolyte.  
 
3.3. Results and Discussion 
 
3.3.1. Molecular architecture of the immunosensor 
Here we report the development of a real-time immunosensor which can perform highly 
sensitive Aβ measurements. The general molecular architecture and working principle of 
the immunosensor is shown in Fiure 3.1. To construct this immunosensor, 3 distinct 
antibodies were placed on each of the barrels of the carbon microelectrode. Antibodies 
mHJ2 placed on E1(40) and mHJ7.4 placed on E2(42) are highly specific to the detection 
of Aβ1-40 and Aβ1-42 respectively. Antibody mHJ5.1 which binds to the central region 
of the Aβ peptide can capture all Aβ isoforms and thus acts as a positive control for the 
immunosensor. The function of antibodies in the developed immunoensor is three-fold 
and needs to be explained in detail. 1) Antibodies capture/bind Aβ molecules to the 
sensor surface which decreases the electron tunneling distance between the sensor surface 
and the Aβ molecules. The decrease in the tunneling distance allows for electrons 
generated due to the oxidation of Aβ to travel to the sensor surface during SWV and 
generate a current signal. Therefore lower quantities of Aβ can also generate a 
measurable signal and improve sensor performance. 2) The capture/binding of Aβ to the 
surface of the carbon fiber eliminates cross talk between the 3 microelectrodes during 
simultaneous measurements of Aβ1-40 and Aβ1-42. 3) Antibodies also enable highly 
specific detection of Aβ1-40 and Aβ1-42.  
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In this work SWV for the oxidation of Aβ was performed so that the magnitude of the 
resultant oxidation peak could be related to the amount of Aβ1-40/42 captured by the 
specific antibodies onto the electrode surface. Parameters involved in the preparation of 
an immunosensor play a vital role on its voltammetric response. Therefore, the 
immunosensor was optimized for a maximum voltammetric response by optimizing key 
parameters such as amount of antibody immobilized on the electrode surface and 
incubation time. A cyclic square wave E-field was applied in order to accelerate the 
movement of antibodies towards the electrode surface which resulted in faster 
immobilization time.  
 
 
Figure 3.1. Schematic illustration of the microbioelectronic detection system for Alzheimer’s disease 
related Aβ1-40 and Aβ1-42 peptides.  
 
3.3.2. Characterization of fabricated triple-barrel carbon fiber microelectrodes 
Carbon fiber microelectrodes have previously been employed for the direct 
electrochemical evaluation of neurotransmitters, enzymes, etc. In addition, the use of 
microelectrodes opens up the possibility of in-vivo application of the immunosensor. The 
miniaturized size of the electrode (several microns in diameter) would allow the careful 
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selection of the biological matrix to be investigated with negligible physical damage to 
the implanted region (Huffman and Venton et al., 2008).  Figure 3.2 shows the image of a 
triple barrel carbon fiber microelectrode obtained using SEM. The SEM image of the tip 
of the electrode shows three distinct disc shaped carbon fibers embedded in an epoxy 
matrix. From the SEM images each of the carbon fibers can be estimated to be 4-5 µm. In 
order to precisely quantify the effective working area of each electrode, cyclic 
voltammetry was conducted. Based on Randles-Sevcik equation (Ipa=(2.69 X 105) n3/2 
AD1/2 v1/2Cred), the electroactive area (A) of all electrodes was determined from the 
anodic peak current (Ipa) obtained in the cyclic voltammograms conducted using 0.03M 
Fe(CN)6-3/-4 (Cred) at a specific scan rate (v) as shown in figure 3.3. The diffusion co-
efficient (D) was taken to be 6.5 X 10-6 cm2s-1 at 20 oC as derived by Kakuichi et al., 
2002 and the average effective working area for each of the microelectrodes was 
calculated to be approximately ~5 μm.   
 
Figure 3.2. SEM image triple barrel carbon fiber microelectrode.  
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Figure 3.3. Cyclic voltammograms of the three barrels of a microelectrode. Measurements were taken in 
0.03 mol/L potassium ferricyanide solution. Scan rate was 0.1 V/s and potential limits were from 0.0 to 
+0.8 V versus Ag/AgCl reference electrode.  
 
3.3.3. Optimization of antibody immobilization parameters 
In the development of electrochemical immunosensors the immobilization of the bio-
recognition element on the electrode is critical towards sensor performance. The surface 
of carbon fibers is well known to exhibit many reactive sites including hydroxylic, 
phenolic and carboxylic functionalities (Pantano and Kuhr, 1991). In order to expose 
these groups, the carbon fiber microelectrodes are electrochemically pretreated 
(Prabhulkar and Li, 2010). The microelectrodes were electroactivated using a 150 mM 
NaCl solution (pH=10) at 1.2 V (vs. Ag/AgCl) for 8 minutes at room temperature. The 
next step towards the construction of the immunosensor was to employ a carbodimide 
reaction to selectively attach the three antibodies on the surface of each of the barrels of 
the microelectrode. In order to test binding of the antibody to the electrode surface, we 
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first conjugated HRP to the antibody. HRP provides a large oxidative signal that is easily 
detected by the electrode; HRP-labeled antibodies were only used to test for antibody 
absorption to the electrode. This involved the incubation of the pretreated 
microelectrodes in EDC and NHSS solutions. Initially the EDC and NHSS solutions were 
prepared in PBS buffer; however a negligible amount of antibody was bound to the 
electrode surface as measured by the electroactivity of the HRP label. We therefore 
switched the buffer to MES which showed a much higher peak from the HRP-labeled 
(mHJ5.1) antibodies as seen in Figure 3.4 
.  
Figure 3.4. DPV response obtained from HRP labeled antibodies immobilized using PBS and MES buffer 
solutions. 
 
HRP-labeled (mHJ.2) antibodies were used to optimize the parameters of the cyclic 
square wave (CSW) E-field which was applied to accelerate the incubation process by 
promoting the transport of the antibodies to the electrode surface (Wei et al., 2009). The 
CSW E-field creates a mass transportation effect in the incubation solution which creates 
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good mixing in shorter time as compared to diffusion kinetics. The voltage applied to 
three electrodes was varied from ±0.1 V to ±0.5 V for equal positive and negative 
cycles. The electrodes were monitored by conducting DPV at every 1 minute interval for 
a period of 12 minutes. Based on the data shown in Figure 3.5 and 3.6 the optimum 
incubation time and applied voltage were chosen as ± 0.3 V and 7 minutes respectively.  
 
Figure 3.5. Bare triple barrel carbon fiber microelectrode incubated with a 1.5 μg/ml solution of HRP 
labeled anti-Aβ antibody (mHJ5.1) solution.  DPV was every 1 minute performed using 10 mM PBS buffer 
and 1 mM KCl as supporting electrolyte. Oxidation peak current is plotted versus responding incubation 
time.  
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Figure 3.6. Effects of driving potential on the amount of antibody immobilized on electrode surface using 
1000 μg/ml antibody solution and incubation time of 7 minutes. 
 
During the immobilization of antibodies on the immunosensor, only a fraction of the total 
antibody applied gets bound to the electrode surface. In order to conserve a precious 
resource such as anti-Aβ antibodies, the optimal concentration was established 
empirically. In these experiments, an electrochemically activated and pretreated 
microelectrode was incubated in solutions ranging from 0.1 to 1.5 µg/ml of mHJ5.1 
antibody. The binding efficiency peaked and plateaued when more than 0.8 µg/ml of 
mHJ5.1 antibody was applied as shown in Figure 3.7. The low binding efficiency can be 
attributed to the presence of hydroxylic and phenolic groups in conjunction to the 
carboxylic groups which are not activated by EDC/NHSS and do not bind antibodies.  
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Figure 3.7. HRP signal generated by electrode following the application of an increasing load of HRP 
labeled antibody. 
 
3.3.4. Immunosensor Performance 
After completing the optimization of key steps in the molecular architecture of the sensor, 
we assessed the ability of the immunosensor to simultaneously quantify Aβ1-40 and 
Aβ1-42 in CSF solutions using SWV with 10 mM PBS and 1 mM KCl as the supporting 
electrolyte. Figure 3.8. shows the voltammetric response obtained after the incubation of 
the microelectrode with four solutions containing equal concentrations of Aβ1-40 and 
Aβ1-42 (0 nM, 100 nM, 500 nM and 1 µM) spiked into rat CSF. In each case when the 
potential was scanned between 0.0 to 0.8 V, a well-defined voltammogram consisting of 
an oxidation peak between 0.6 to 0.65 V was obtained. The oxidation current was 
obtained almost instantaneously in our experiments with no delay needed for equilibrium. 
Further, no stringent temperature control was required during electrochemical evaluation. 
The signal obtained for E3(TOT) which acts as the control electrode was always higher 
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as compared to the signals obtained for E1(40) and E2(42). The response obtained for 
E3(TOT) correlates with the activity of the mHJ5.1 antibody which recognizes most 
isoforms of Aβ as it is targeted towards the central region of the peptide.  
 
Figure 3.8. Square wave voltammetric responses of 3 barrel of the immunosensors obtained in rat 
cerebrospinal fluid solution, spiked with 100 nM Aβ1-40 and 100 nM Aβ1-42, 500 nM Aβ1-40 and 500 
nM Aβ1-42, 1 μM Aβ1-40 and 1 μM Aβ1-42 solutions. Square wave voltammetry parameters: Init E (V) 
=1; Final E (V) =0; Incr E (V)= 0.004; Amplitude (V) = 0.04; Frequency (Hz) = 500. 
  
Linear calibration plots shown in figure 3.9A and 3.9B were then constructed based on 
peak oxidation currents obtained vs. Aβ1-40 and Aβ1-42 concentrations respectively, in 
order to normalize the variations between electrodes. Based on the evaluation of the 
calibration plots Aβ1-40 and Aβ1-42 could be specifically detected in CSF from rat 
within a detection limit of 400 nM to 1 μM and 100 nM to 1.2 μM respectively. The 
discrepancy observed with the detection capabilities of the immunosensor towards Aβ1-
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40 and Aβ1-42 detection might be for several reasons including: 1) related to the inherent 
immunoreaction kinetics of each antibody, 2) differential aggregation of Aβ which could 
limit signal multimers, 3) more non-specific absorption (“sticking”) of Aβ1-42 versus 
Aβ1-40 to the apparatus. 
 
 
Figure 3.9. (A) Calibration curve: the relationship between peak oxidation current and Aβ1-40 
concentration. (B) Calibration curve: the linear relationship between peak oxidation current and Aβ1-42 
concentration.  
 
Specificity is a crucial parameter which influences the performance of an immunosensor 
in real matrices, especially when an analyte at low concentrations needs to be detected in 
the presence of a much larger concentration of non-specific molecules. We need to prove 
that the presented sensor responds only to the Aβ and anti-Aβ immunoreaction and not to 
the nonspecific adsorption of other proteins. CSF contains free tyrosine and other 
proteins containing tyrosine amino acid residues, which could cause false signaling. 
Ethanolamine which has been proven to be a successful blocking agent in previous 
studies (Frederix et al., 2004) was used to minimize these non-specific binding reactions. 
In order to measure the specificity of each of the barrels towards a specific Aβ isotope, 
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three immunosensors were challenged using each of the following solutions 1) 1000 nM 
Aβ1-40 2) 1000 nM Aβ1-42 and 3) 500 nM Aβ1-40 and 500 nM Aβ1-42.  SWV was 
performed before and after incubation of each microelectrode with analyte solution. 
Figure 3.10 shows the average values of peak oxidation currents obtained after incubation 
from each of the barrel of three separate electrodes incubated in each of the 
abovementioned solutions. From the evaluation of figure 3.10 we can deduce that each of 
the barrels showed highly specific recognition properties. The signal obtained due the 
non-specific adsorption of non-Aβ proteins and non-corresponding Aβ isoforms from 
each of the barrels was found to be minimum and statistically insignificant.  
 
 
 
 
 
 
 
 
 
 
 
63 
 
Figure 3.10. Oxidation peak current obtained from three anti-Aβ modified carbon fiber microelectrodes 
after being incubated with 1 μM of Aβ1-40, 1μM of Aβ1-42 and 500nM of Aβ1-40 + 500 nM of Aβ1-42 
spiked into rat cerebrospinal fluid solutions respectively. Measurements were performed in 10 mM PBS 
buffer and 1mM KCl versus Ag/AgCl. 
 
The stability of the microelectrodes with anti-Aβ antibodies immobilized on their surface 
was evaluated over a period of one month. The micro immunosensors were stored in 0.1 
M PBS solution at 4 oC after fabrication. The stability of the stored electrodes was 
studied by incubating them in freshly prepared solution containing 0.1 % BSA, 500 nM 
Aβ1-40, 500 nM Aβ1-42 in 0.1 M PBS at pH 7.2. The stability of the electrodes was 
evaluated by measuring their electrochemical response using square wave voltammetry. 
The electrochemical response of the microelectrodes progressively degraded after 4 days 
in storage.  To test the inter-sensor reproducibility of the proposed system, three samples 
of different concentrations (100, 500 and 1000 nM) of Aβ1-40 and Aβ1-42 were tested 
first with different electrodes. This indicates that our detection strategy offers an 
acceptable reproducibility towards the detection of Aβ1-40 and Aβ1-42. 
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3.4. Conclusion 
 
In this work, a simple, sensitive and fast electrochemical multiplexed immunoaasay for 
Alzheimer’s disease biomarkers is presented.  The current signal generated due to the 
oxidation of Aβ was demonstrated to be feasible in the development of a direct, one-step 
biosensor. The reagentless detection process based on the inherent electroactivity of Aβ 
greatly simplifies the sensor utilization. The incorporation of an electric field-driven 
strategy greatly shortened the sensor fabrication and response time to 7 minutes enabling 
real-time measurement of Aβ. The results show detection limit of sensor towards Aβ-40 
and Aβ-42 to be 400 nM and 100nM respectively. The single use sensor displays 
specificity towards respective Aβ isoform and no cross-talk between the barrels of the 
microelectrode. The detction strategy enables the direct detection of electroactive 
biomolecules and can be generally used for the detection of any other electroactive 
biomarker by using an appropriate antibody. The limitations of the detection strategy are 
that sensitivity is compromised as compared to the approach described in Chapter 2, due 
to direct measurement. In addition, incubation time of 7 minutes is still long as some 
biological reactions occur on the scale of seconds. To remedy these shortcomings the 
direct dtection strategy was developed in Chapter 4.  
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Chapter 4 
Assessment of oxidative DNA damage and repair at single cellular level via real-time 
monitoring of 8-OHdG biomarker 
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4.1. Introduction 
 
Reactive oxygen species (ROS) or free radicals have been implicated as the cause of 
cancer, diabetes, cardiovascular disease, and neurodegenerative diseases (Wu et al., 
2004). In living cells, endogenous ROS are produced as a result of various metabolic, 
physiological processes, and other biochemical reactions. The cell can protect itself from 
ROS using enzymes such as superoxide dismutases, catalases, lactoperoxidases, and 
glutathione peroxidases. Antioxidants such as ascorbic acid, tocopherol, glutathione and 
uric acid present in the cell, act as scavengers of ROS (Jackson and Loeb, 2001). Under 
normal physiological conditions a balance is maintained between the endogenous ROS 
and antioxidants. However, an imbalance can be caused due to a drop in the level of 
antioxidants or an increase in the level of ROS from exogenous sources such as cigarette 
smoke, UV or ionizing radiation, hazardous chemicals, inflammation, etc. (Martin and 
Barrett, 2002).  When an imbalance occurs lipids, proteins and nucleic acids present in 
the cell may undergo oxidative damage.  The site of oxidative damage is usually nuclear 
and mitochondrial DNA in tissue. Numerous DNA damage products are formed during 
oxidative damage due to bases and sugar modifications, covalent crosslinks, single and 
double stranded breaks. However, most research interest has focused on nucleobase 
modifications (Cooke et al., 2003). Among the common DNA nucleobases, guanine has 
the lowest oxidation potential and is the most prone to oxidative damage. Nucleobases 
such as 8-hydroxyguanine (8-OxoG) are less common but act as deep traps for radical 
cations since they have a much lower oxidation potential than guanine (Kanvah and 
Schuster, 2006). Upon oxidation of 8-OxoG, a hydroxyl group is added to the 8th 
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position of the guanine molecule and the oxidatively modified product is called 8-OHdG 
(Floyd et al, 1986). DNA damage lesions such as 8-OHdG are recognized and cleaved by 
the base excision repair mechanism (BER). Once recognized, 8-OHdG is cleaved by 
enzymes such as endonuclease and glycosylase to prevent DNA mutations (Hollstein et 
al., 1991; Cheng et al., 1992). 8-OHdG being water soluble is secreted out of the cell into 
the extracellular space after being removed from the DNA helix.  Thus monitoring 
extracellular 8-OHdG will provide insight into oxidative DNA damage (formation of 8-
OHdG) and DNA repair mechanisms (cleavage of 8-OHdG) (Zhang et al., 2006).  
8-OHdG was first discovered by Kasai and Nishimura in 1984 during their attempt to 
study and isolate mutagens in heated glucose (Kasai et al., 1984). Thereafter, numerous 
papers have analyzed 8-OHdG levels in human organs, cell lines, and body fluids in 
relation to oxidative stress, diet, cancer incidence, aging, heart disease and neurological 
disorders. On account of these studies, 8-OHdG has been established as a crucial 
biomarker of oxidative stress (Kasai, 1997; Shigenaga et al., 1989), cancer instigation by 
free radicals (Halliwell 1998; Marnett 2000), and aging including degenerative diseases 
(Fraga et al., 1990; Sayre et al., 2001). 8-OHdG is also a biological marker of lifestyle 
and the effects of diet (Kasai et al., 2001; Halliwell, 2002). The significance of 8-OHdG 
is such that a search done on Google Scholar for articles published during the last 20 
years showed about 6,680 papers.  
Electrochemical detection of 8-OHdG is possible as it undergoes oxidation via a two-
electron two-proton charge transfer reaction, shown in figure 4.1. (Goyal et al., 1997).   
Due to the dissociation of protons the oxidation potential of 8-OHdG is heavily 
dependent upon the pH of the supporting electrolyte (Li et al., 2007). The rate of the 
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charge transfer reaction has been observed to be fastest at the surface of carbonaceous 
electrodes (Langmaier et al., 2003). Carbon-fiber microelectrodes were introduced by 
Pujol et al. nearly 30 years ago, who used them with normal pulse polarography to 
measure the oxidation of several neurotransmitters, including dopamine, norepinephrine 
and serotonin (Ponchon et al., 1979). Since then, the most popular applications for carbon 
fiber electrodes have been as sensors for in-vivo detection of neurotransmitters. Carbon 
fiber microelectrodes have been used for biological applications due to advantages such 
as: excellent biocompatibility and non-toxicity towards cells, good electrochemical 
properties which have been extensively studied and characterized, miniature size (<10 
μm in diameter) of electrodes makes them ideal for implantation with minimal damage to 
cells, enable rapid measurements when used with fast electrochemical techniques such as 
amperometry, chronoamperometry and fast scan cyclic voltammetry.  
 
 
Figure 4.1. Schematic showing the electroactive behavior of 8-OHdG. 
 
Classic analytical methods used for the detection of 8-OHdG include high-performance 
liquid chromatography with electrochemical detection (HPLC-ED) (Martinis and De 
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Lourdes, 2002), gas-chromatography-mass spectroscopy (GC-MS) (Teixeira et al., 1993), 
enzyme-linked immunosorbent assay (ELISA) (Chiou et al., 2003), 
immunohistochemical methods (Toyokuni et al., 1997), and single cell gel 
electrophoresis (comet assay) (Hartmann et al., 1998). These methods have been 
successfully used to analyze 8-OHdG in animal and human organs, fluid samples (urine, 
saliva, and cerebrospinal fluid) and cell lysates. Techniques such as ELISA, HPLC-ED, 
and GC-MS when used to monitor 8-OHdG levels in cell lysates or cell media report the 
average behavior of cells in a population, thus concealing any cell to cell variations that 
may characterize each cell’s survival under stress. Current techniques to determine 8-
OHdG in single cells are immunostaining, and comet assay. These techniques can 
monitor cells only at a single time point and therefore do not allow for real-time 
monitoring. Also, these techniques have been developed to look at the intracellular 8-
OHdG deposits. To overcome the disadvantages of the current techniques, we report a 
strategy to measure extracellular levels of 8-OHdG in real time.  
In our previous studies, we have successfully used carbon fiber microelectrodes to detect 
analytes such as vascular endothelial growth factor and nitric oxide (Prabhulkar et al., 
2009; Li et al., 2009). Activated carbon nanotube based electrodes have been effectively 
used for the simultaneous detection of neurotransmitters (Alwarappan et al., 2009; 
Alwarappan et al., 2010). In this study, we have detected extracellular 8-OHdG secreted 
from single lung epithelial cells exposed to varying concentrations of nicotine using 
carbon fiber microelectrodes. Cigarette smoking and chewing tobacco have been linked 
to the development of several cancers such as lung, oral, esophageal and bladder 
(Boffetta et al., 2005; Campain, 2004). Nicotine, which is responsible for the addictive 
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nature of tobacco use, is also one of the most biologically active chemicals present in 
cigarette smoke and smokeless tobacco. Due to its highly reactive nature, nicotine has 
been implicated in free radical generation in rodent and human cells of various types 
(Wetscher et al., 1995; Wetscher et al., 1995; Ferger et al., 1998). Nicotine is also the 
precursor to many tobacco carcinogens (Wu et al., 2005). Most of the research conducted 
to determine the mutagenicity of nicotine shows inconsistent findings (Doolittle et al., 
1995; Trivedi et al., 1990). Therefore, there is a need for further exploration to clarify this 
issue.  
 
4.2. Experimental 
 
4.2.1 Materials 
 Carbon fibers (5 μm in dia.) were friendly donated by World Precision Instruments 
(Sarasota, FL).   Borosilicate glass capillaries (outer dia. 0.5 mm, inner dia 0.3 mm) were 
obtained from Sutter Instrument Company (Novato, CA). Sylgard 184 was obtained from 
Dow Corning Corporation (Midland, MI). Human alveolar epithelial cell line L-132 was 
purchased from American Type Culture Collection (VA, USA). Dulbecco's Modified 
Eagle Medium and 10 % heat-inactivated fetal bovine serum were purchased from Gibco 
BRL (Grand Island, NY). 8-OHdG stock solution was obtained from Biolog Inc. 
(Hayward, CA) at a concentration of 5 μmol. Calcium Ionophore (A23187), hydrogen 
peroxide (≥97%), nicotine (≥9 9%), and other reagents were purchased from Sigma-
Aldrich (St. Louis, MO).  
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4.2.2 Instrumentation 
Carbon fiber microelectrodes were prepared using P-97 Micropipette Puller and BV-10 
Beveller acquired from Sutter Instrument Company (Novato, CA).  Electrochemical 
measurements were carried out using the 600C Electrochemical Analyzer attached to a 
Picoamp Booster from CH Instruments, Inc. (Austin, TX). PV830 Pneumatic Picopump 
purchased from World Precision Instruments (Sarasota, FL). LU-CB1 Leiden 
microincubator purchased from Harvard Apparatus (Holliston, MA). MS3114 
micromanipulators purchased from World Precision Instruments (Sarasota, FL), one to 
position the working electrode for the cell and the second to position the injection pipette 
containing the secretagogue. Faraday Cage and Anti-Vibration Workstation purchased 
from Kinetic Systems, Inc. (Boston, MA). A conventional three electrode cell consisting 
of an Ag/AgCl reference electrode (3 M KCl) (Bioanalytical Systems, IN, USA), and a 
platinum wire as an auxiliary electrode was employed.  
 
4.2.3. Preparation and activation of carbon fiber microelectrodes 
Carbon fiber microelectrodes were fabricated using the method described in our previous 
work (Prabhulkar et al., 2009). Briefly, a single carbon fiber of diameter 5 μm was 
attached to the stripped end of an insulated copper wire (dia. 0.2 mm) using a silver 
conductive paste. The silver paste was allowed to dry, after which the free end of the 
copper wire was cannulated into a borosilicate glass capillary. The copper wire was fixed 
to the capillary using a fast drying epoxy resin. The capillary was then pulled using a 
micropipette puller. This pulling procedure results in two glass pipettes, one of which is 
discarded, and the other part which holds the carbon fiber protruding from its tip. The 
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junction between the carbon fiber and capillary is sealed with a drop of the Sylgard 
silicone preparation and allowed to cure until it becomes firm. The microelectrodes were 
then beveled at 45o using diamond abrasive plate, to obtain a disk shaped active electrode 
surface. The carbon fiber surface was then cleaned by 5 second sonication in acetone, 1 
M nitric acid, 1 M KOH and distilled water sequentially. The microelectrodes were 
electroactivated using a 150 mM NaCl solution (pH=10) at 1.2 V (vs. Ag/AgCl) for 8 
minutes at room temperature. 
 
4.2.4. Cell culture of lung endothelial cells 
Human alveolar epithelial cells were cultured in Dulbecco's Modified Eagle Medium 
supplemented with 10% heat-inactivated fetal bovine serum. The cells were stored at 
37 °C in 5% CO2, 95% O2 in a humidified cell incubator. The cell medium was changed 
every 48 hours.  
 
4.2.5. Calibration of microelectrode for 8-OHdG measurements 
Standard solutions of different concentrations (10 pM, 20 pM, 30 pM, 40 pM, 50 pM and 
60 pM) were made by gradually diluting the 8-OHdG stock solution using 0.1 M 
phosphate buffer saline (PBS) at pH=7, which correlates to physiological pH. Calibration 
of the microelectrode for 8-OHdG detection was carried out using CPA, with the 
potential on the microelectrode held at 0.42 V (vs. Ag/AgCl). The microelectrode to be 
tested and a microcapillary (inner diameter 20 μm) were both placed in petri dish 
containing saline buffer (137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 25 nM HEPES, 
10 mM glucose, 2 mM CaCl2 at pH=7.2). The tip of the carbon fiber microelectrode was 
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placed at the outlet of the microcapillary as shown in figure 4.2.  The microcapillary 
filled with 8-OHdG standard solution was connected to the PV830 Pneumatic Picopump. 
This calibration system was used to simulate the situation of 8-OHdG detection near the 
surface of a single cell. 
 
Figure 4.2. View of calibration system to measure 8-OHdG response at the surface of an activated carbon 
fiber microelectrode. 
 
4.2.6. Single-cell measurements 
Prior to experimentation, cell culture media was discarded and the petri dishes (35 mm 
outer diameter X 10 mm high) containing 1 x 102 cells were rinsed twice with a saline 
buffer. The petri dish was refilled with saline buffer warmed to 37 oC and placed on the 
LU-CB1 Leiden microincubator. The microincubator placed on the stage of an inverted 
microscope, maintains the cell bath temperature to 37 oC and the CO2 content to 5%. A 
single isolated cell was located with the microscope and an activated carbon fiber 
microelectrode was positioned at a distance 0.5 μm over its surface using the MS3114 
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micromanipulators as shown in figure 4.3. All the experiments were isolated from 
electromagnetic interference and physical disturbances using a Faraday Cage and an 
Anti-Vibration Workstation. Any cables running into the Faraday Cage were additionally 
shielded using aluminum tape. Secretagogues, such as Calcium Ionophore (A23187) were 
applied to the cell via pressure ejection from the tips of micropipettes (inner diameter 20 
μm) placed at a distance of 1 cm from the cell. Flow rate through the pipette tips was 
determined to be 0.2 μL/s. Hydrogen peroxide was used as a positive control to induce 
oxidative DNA damage while a saline buffer was used as a negative control. Cells were 
treated with 10 mM hydrogen peroxide dissolved in the cell bath solution. Nicotine was 
introduced at varying concentrations into the cell bath solution in order to study its effects 
on DNA damage and 8-OHdG secretion.   
 
Figure 4.3. View of the detection system in single cell experiments. A carbon fiber microelectrode was 
placed at a fixed distance of 0.5µm away from the surface of a cell. 
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4.2.7. Electrochemical measurements 
CPA in conjunction with Fast Scan Cyclic Voltammetry (FSCV) was used to monitor 8-
OHdG release from single cells. CPA was performed by holding the microelectrode at 
constant potential of 0.42 V. FSCV was performed in the potential window of 0.2 to 0.8 
V, at a scan rate of 200 V/s. Background CPA and FSCV measurements were conducted 
at the surface of the cell in bath buffer before addition of hydrogen peroxide or nicotine. 
In order to eliminate noise and enhance signal the background measurements were 
subtracted from the averaged CPA and FSCV measurements conducted at cells under the 
influence of hydrogen peroxide or nicotine  
 
4.3. Results and discussion 
 
4.3.1 Calibration for 8-OHdG 
A typical amperometric response to the injection of 8-OHdG is shown in figure 4.4. After 
each injection the activated carbon fiber microelectrode displayed a quick amperometric 
response which reaches a maximum plateau value and then rapidly drops. A calibration 
curve of peak amperometric response against the corresponding 8-OHdG standard 
solution concentration was plotted in figure 4.5. The calibration curve indicates that the 
activated microelectrode displayed a linear response from 10 pM to 60 pM solution of 8-
OHdG. The linear response of the microelectrode proves that it is well suited for the 
direct detection of 8-OHdG.  
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Figure 4.4. Typical amperometric response to the injection of 10 pM, 20 pM, 30 pM, 40 pM, 50 pM, and 
60pM 8-OHdG by using the calibration system. 
 
Figure 4.5. The calibration curve for microelectrode response towards 8-OHdG solution over the 
concentration range of 10–60 pM. 
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4.3.2. Detection of 8-OHdG secretion from single lung epithelial cells 
 Initially, in order to establish a negative control or background readings, electrochemical 
measurements were conducted at the surface of a single isolated cell incubated in saline 
buffer. An activated carbon fiber microelectrode (working electrode) was positioned at 
0.5 µm above the cell surface, Ag/AgCl electrode (reference electrode) and a 0.5 mm 
diameter platinum wire (counter electrode) were also placed in the saline buffer. Calcium 
ionophore (A21387) was used in order to stimulate exocytosis in cells.  A21387 
facilitates the influx of Ca2+ from the bath buffer into the cell. This results in an 
escalation of free intracellular Ca2+ which triggers rapid exocytosis. 500 µM calcium 
ionophore dissolved in dimethyl sulfoxide was injected at rate of 0.2 μL/s at a distance of 
1 cm from the cell under study using the Picopump. The actual concentration of 
ionophore affecting the cell would be far less due to its diffusion into the cell bath 
solution. Secretion of 8-OHdG from the single cell surface was mapped using CPA and 
FSCV. Cells were monitored using CPA for a period of 2 hours with calcium ionophore 
stimulation applied every 100 seconds. Figure 4.6. shows the CPA response of the 
microelectrode recorded at the surface of a single lung cell incubated in saline buffer. We 
do not observe any current peaks higher than the background signal, which indicates that 
significant secretion of 8-OHdG from cell was not observed in the saline buffer.  
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Figure 4.6. Current recordings made at a single lung endothelial cell in saline buffer with the electrode 
potential was held at +0.42 V. The bars indicate calcium ionophore injection via microcapillary placed 1 
cm from cell surface. 
 
Hydrogen peroxide was used as a positive control or model ROS to induce oxidative 
damage in lung epithelial cells (Halliwell and Aruoma, 1991). Hydrogen peroxide has 
been proven to cause DNA strand breakage and is highly correlated with multiple 
chemical modifications of DNA bases, suggesting damage due to hydroxyl radical 
(Spencer et al., 1995). In order to induce oxidative DNA damage, lung epithelial cells 
were subjected to 10 mM hydrogen peroxide solution made using saline buffer. 
Electrochemical recording was started 15 minutes after incubating cells with saline 
solution containing hydrogen peroxide. Hydrogen peroxide was present in the cell bath 
during the entire course of the CPA measurements. These experiments were conducted as 
a proof of concept to verify if 8-OHdG release could be recorded from a single lung 
epithelial cell. CPA was conducted at the cell surface using calcium ionophore 
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stimulation. From the background subtracted CPA signal shown in figure 4.7., we 
observe that 8-OHdG is sporadically released after stimulation. The average peak current 
calculated by taking into account peaks obtained during the first three stimulations given 
to 20 different cells is 6.17±0.5 pA.  
 
Figure 4.7. Current recordings made at single lung endothelial cell with 10mM hydrogen peroxide 
exposure. The bars indicate calcium ionophore injection via microcapillary placed 1 cm from cell surface. 
 
We also conducted repetitive FSCV measurements at the surface of the cells. The 
background subtracted voltammogram shown in figure 4.8. shows an oxidation peak at 
0.42 V (Ag/AgCl) which corresponds to the electrochemical behavior of 8-OHdG (Li et 
al., 2007; Wan et al., 2008; Brett et al., 2000). Therefore, using CPA we were able to 
record the release kinetics of 8-OHdG from the surface of a single lung epithelial. Based 
on the oxidation peak observed in the background subtracted FSCV signal, we are able to 
verify that the analyte being measured by the microelectrode is in fact 8-OHdG.   
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Figure 4.8. Background subtracted fast scan cyclic voltammogram at the surface of single lung epithelial 
cell incubated with 10mM hydrogen peroxide. The potential sweep was carried out from 0.2 to 0.8 V, at a 
scan rate of 200 V/s. 
 
4.3.3. Test effects of nicotine on oxidative DNA damage and repair / Test effects of 
nicotine on 8-OHdG secretion 
The concentration of nicotine in the plasma and saliva of smokers can reach up to 100 
ng/mL (0.0006 mM) and 4000 ng/ml (0.025 mM), respectively (Hukkanen et al., 2005; 
Schneider et al., 2001; Teneggi et al., 2002). In order to conduct our studies at a 
physiologically relevant range, we have tested lung epithelial cell exposure to 0.025, 
0.05, 0.1, 0.5, 1, 2, 4, 6 and 8 mM of pure nicotine dissolved in the saline cell bath buffer. 
In order to study the time release kinetics of 8-OHdG secretion, single lung epithelial 
cells were monitored up to a period of 2 hours. Figure 4.9. shows the image of a healthy 
attached cell present in saline buffer solution, recorded two hours after the petri dish was 
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placed on the microincubator. This image demonstrates that the lung epithelial cells are 
healthy for the entire duration of the electrochemical investigation.     
 
Figure 4.9.  Image of single lung epithelial cell in saline buffer solution, recorded 2h after the petri dish was 
placed on the microincubator. 
 
4.3.3.1. Concentration effects of nicotine 
 Nicotine was dissolved in the saline buffer to obtain standard test solutions from 0.025 to 
8 mM. Figure 4.10. shows the background subtracted CPA signal recorded at the surface 
of a single lung epithelial cell exposed to 4mM nicotine solution. Therefore, we 
confirmed that 8-OHdG is released from a single cell under the influence of nicotine, 
after calcium ionophore stimulation.  
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Figure 4.10. Current recordings made at a single lung endothelial cell in saline buffer with the electrode 
potential was held at +0.42 V. The bars indicate calcium ionophore injection via microcapillary placed 1 
cm from cell surface. 
 
Figure 4.11. shows results of average peak currents obtained from 3 individual cells 
subjected to each standard nicotine solution for a period of 1 hour. We did not observe 
any peaks greater than the background signal for exposure to nicotine solution of 0.025, 
0.05, 0.1, 0.5, and 1 mM of nicotine solutions. However 8-OHdG secretion displayed a 
dose related response for nicotine exposures of 2, 4, 6 and 8 mM. Instantaneous cell 
detachment was observed for nicotine exposures over 9 mM, as shown in figure 4.12. 
These results are in concordance with studies performed by Yildiz, to compare the 
formation of 8-OHdG in Chinese Hamster Ovary cells due to nicotine and smokeless 
tobacco extract containing the same amounts of nicotine (Yildiz, 2004). 
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Figure 4.11. Average peak currents obtained from 3 individual isolated cells after 1 h of incubation with 
0.025, 0.05, 0.1, 0.5, 1, 2, 4, 6, and 8mM nicotine solution respectively.  
 
 
Figure 4.12. Image of detached and unhealthy lung epithelial cells, recorded after the addition of 9mM 
nicotine solution. 
4.3.3.2. Time effects of 8-OHdG nicotine induced measurements 
CPA was used to study the release kinetics of 8-OHdG from single lung epithelial cells 
exposed to 4 mM of nicotine, as shown in Fig. 4.13. A 4 mM nicotine solution was 
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selected to study the time release kinetics as this concentration of nicotine lies at the 
center of the damage causing range of 2 to 8 mM, as observed from our previous 
experiments. 20 individual isolated cells were studied under similar experimental 
conditions for a period of 2 hours. The same carbon fiber microelectrode was used to 
study each of the cells to eliminate any variability due to sensor response. The carbon 
fiber microelectrode was cleaned and pretreated before analyzing every cell.  Calcium 
ionophore stimulation was given every 100 seconds. The first 8-OHdG secretion peaks 
were observed at an average time period of 12.37±1.5 minutes as shown in Fig. 4.13. 
The amount of 8-OHdG secreted thereafter escalated until it reached a plateau period 
between 47±2.3 and 82±2.3 minutes. Following the plateau, 8-OHdG secretion 
decreased and finally ceased after an average of 110±3.8 minutes. The cessation of 8-
OHdG secretion can be related to the inhibition of DNA repair by the base excision repair 
pathway. DNA repair suppression has also been reported during exposure of cells to 
oxidants such as hydrogen peroxide (Hu et al., 1995; Li et al., 2000), formaldehyde 
(Grafstrom et al., 1983) and nicotine (Kozlovskis-Wade et al., 1998).  
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Figure 4.13. Average current recordings made at the surface of 20 single isolated lung epithelial cells with 
4mM nicotine exposure for a period of 2 h.  
 
4.4. Conclusions 
 
In this study, we have monitored the release kinetics of 8-OHdG at the surface of a single 
lung epithelial cell using an activated carbon fiber microelectrode. To the best of our 
knowledge, this is the first report showing direct and continuous measurements of 8-
OHdG release at the surface of a single isolated cell. Activated carbon fiber 
microelectrodes exhibit excellent sensitivity towards 8-OHdG, discerning currents as 
small as 1 pA. FSCV conducted to verify the release of 8-OHdG showed an oxidation 
peak at 0.42 V. Lung epithelial cells were incubated with varying concentrations of 
nicotine in order to study its genotoxic effects. Nicotine showed a dose dependent 
increase in DNA damage which was mirrored in the amount of 8-OHdG secreted. 
Studying the temporal release kinetics reveals cessation of 8-OHdG after 110 minutes of 
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exposure to 4 mM nicotine. We have outlined a highly sensitive strategy for the real time 
measurements of 8-OHdG at a single cell level. It is hopeful that a similar strategy may 
be employed to detect 8-OHdG in-vivo. Multiple carbon fiber nanoelectrodes may also 
be used to determine spatial distribution of 8-OHdG release from a single cell. 
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Chapter 5 
Conclusions and Future Work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1. Conclusions 
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Electrochemical sensors developed to measure disease biomarkers allow us to diagnose 
and study diseases such as cancer and Alzheimer’s. Electrochemical detection allows 
highly sensitive, real-time detection of biomarkers in solution and at the surface of single 
cells. Incorporation of antibodies to the sensor surface enhances sensitivity and imparts 
specificity. This thesis mainly deals with the development of direct, one-step 
microsensors towards measurement of disease biomakers.  
Chapter 2 deals with the development of a direct reagentless immunosensor for the 
detection of VEGF. A highly sensitive, reagentless, electrochemical strategy is reported 
for the detection of a cancer biomarker VEGF. Disc shaped carbon fiber microelectrodes 
were used as the immunosensor platform. Ferrocene monocarboxylic acid labeled anti-
VEGF was covalently immobilized on the microelectrode surface using a Jeffamine 
cross-linker. The formation of immuno- complexes leads to a decrease in the 
electrochemical signal of ferrocene monocarboxylic acid owing to increased spatial 
blocking of microelectrode surface. These signal changes enable quantitative detection of 
VEGF in solution. Voltammetric measurements were conducted to evaluate the 
interfacial immunore- actions and to quantitatively detect VEGF biomarker. The 
proposed immunosensing strategy allows a rapid and sensitive means of VEGF analysis 
with a limit of detection of about 38 pg/mL. This opens up the possibility of employing 
these electrodes for various single cell analysis and clinical applications. Further, 
experimental conditions such as concentration of the immobilized antibodies and 
incubation period were optimized. Following this, the stability and specificity of the 
immunosensors were also evaluated.  
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Chapter 3 describes the development of a multiplex, direct immunosensor for the 
detection of Aβ isoforms which are key biomarkers related to AD. AD affects about 35.6 
million people worldwide, and if current trends continue with no medical advancement, 1 
in 85 people will be affected by 2050. Thus, there is an urgent need to develop a cost 
effective, easy to use, sensor platform to diagnose and study AD. The measurement of 
peptide Aβ found in CSF has been assessed as an avenue to diagnose and study the 
disease. The quantification of the ratio of Aβ1-40/42 (or Aβ ratio) has been established as 
a reliable test to diagnose AD through human clinical trials. Therefore we have developed 
a multiplexed, implantable immunosensor to detect Aβ isoforms using triple barrel 
carbon fiber microelectrodes as the sensor platform. Antibodies act as the biorecognition 
element of the sensor and selectively capture and bind Aβ1-40 and Aβ1-42 to the 
electrode surface. Electrochemistry was used to measure the intrinsic oxidation signal of 
Aβ at 0.65 V (vs Ag/AgCl), originating from a single Tyr residue found at position 10 in 
its amino acid sequence. Using the proposed immunosensor Aβ1-40 and Aβ1-42 could be 
specifically detected in CSF from mice within a detection range of 100nM to 1.2μM and 
400nM to 1μM respectively.  The immunosensor enables real-time, highly sensitive 
detection of Aβ and opens up the possibilities for diagnostic ex-vivo applications and 
research-based in-vivo studies.  
Chapter 4 involves the mesurement of DNA damage biomarker 8-OHdG at the surface of 
single cells under the influence of ROS. 8-OHdG is the most important and best-
documented biomarker of oxidative stress, which is involved in the instigation of various 
diseases. 8-OHdG levels correlate to oxidative DNA damage which is known to be the 
root cause of a variety of age-related chronic diseases. The purpose of our research was to 
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develop a detection strategy capable of measuring 8-OHdG in real-time at the surface of a 
single cell. Activated carbon fiber microelectrodes were used as the sensing platform. 
The microelectrodes were used to measure 8-OHdG release from single lung epithelial 
cells under the influence of nicotine. In order to evaluate the direct role of nicotine in 
tobacco induced genotoxicity, we studied the influence of parameters such as nicotine 
concentration and exposure times on 8-OHdG secretion. 2–8 mM nicotine solutions 
induced dose-dependent DNA damage in single cells, which was observed via 
amperometric measurements of secreted 8-OHdG biomarker. Real-time 8-OHdG 
measure- ments from single cells exposed to 4 mM nicotine solution revealed cessation 
of 8-OHdG secretion after 110 min. We have successfully outlined a methodology to 
detect 8-OHdG at the surface of single cells. A similar protocol can be used to evaluate 
oxidative DNA damage and repair mechanisms in other disease models. 
 
5.2. Future Work 
 
The multiplex sensor developed for the detection Aβ isoforms will be further tested in-
vivo using amyloid precursor protein transgenic mice. The triple barell sensors will 
further used to study the effects of drug candidates on Aβ production or clearance.   
Electrochemical measurements of 8-OHdG at the surface of single cells will be using 
chip based microfluidic sensors. Micro-wells capable of capturing a single cell and 
containing a gold/carbon electrode at the base of the well will be fabricated. 8-OHdG 
measurements will be performed under the effects of anti-oxidants and pro-oxidants. 
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